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SUMMARY 
 
This study retrospectively analysed the bacteriology of 226 patients who were 
admitted, with acute complicated sinusitis, to the University of the 
Witwatersrand’s ENT complex over a 5-year period, between the 1st January 
2002 and 31st December 2006. There were 159 male and 67 females (ratio 
2.4:1) aged between 1 and 74 (mean 16.5 ± 0.7) years. 116 (51.3%) patients 
were 15 years and younger and 110 (48.7%) were above the age of 15 years. 
 
All 226 patients had one or more of an orbital, soft tissue or bony 
complication and underwent open sinus surgery by way of an external 
frontoethmoidectomy approach (or ethmoidectomy) with maxillary sinus 
puncture and sinus washout. Intracranial complications were present in 37 
(16.4%) patients of whom 12 required drainage of a subdural empyema and, 
one required drainage of a brain abscess. 
 
233 microorganisms were isolated for analysis from positive cultures obtained 
from 163 (72.1%) patients (1.4 isolates per specimen) and 63 (27.9%) cultures 
were negative. Aerobic and facultative anaerobes accounted for 199 (85.4%) 
of the isolates whilst anaerobes accounted for 31 (13.3%) and fungi for 3 
(1.3%). 107 (65.4%) of the positive culture specimens were monomicrobial 
whilst 56 (34.6%) contained 2 to 4 different species of microorganism. The 
proportion of anaerobes was notably higher (p<0.05) polymicrobial specimen 
than in monomicrobial specimen. 
 
 xi
The most commonly isolated aerobic microorganisms were Streptococcus 
milleri (18.5%), Staphylococcus aureus (12.4%), β-haemolytic streptococci 
groups A, C, F, and G (10.3%), coagulase negative staphylococcus (8.6%) and 
Haemophilus influenzae (8.6%). In contrast, Streptococcus pneumoniae 
(2.6%) and Moraxella catarrhalis (0.4%) were not major pathogens. 
 
Peptostreptococcus (6.4%) and Prevotella (4.7%) species were the most 
common anaerobes. 
 
The profile of isolates was not influenced by gender or by the presence of 
intracranial complications. However, age and location did have a significant 
(p<0.05) impact. Haemophilus influenzae was more significant (p<0.05) in 
patients aged 15 years and younger. Streptococcus milleri was the most 
common isolate (28.3%) at the Chris Hani Baragwanath Hospital but ranked 
5th (2.3%) at the Johannesburg Hospital. β-haemolytic streptococci and 
coagulase negative staphylococcus ranked 1st (20.8%) and  2nd (14.8%) 
respectively at the Johannesburg Hospital but only 4th (4.8%) and 5th (2.8%) 
respectively at the Chris Hani Baragwanath Hospital. 
 
Penicillin, ampicillin and erythromycin were effective against Streptococcus 
milleri, β-haemolytic streptococci, Streptococcus pneumoniae and 
streptococcal species. Cloxacillin was effective against Staphylococcus aureus 
and coagulase negative staphylococci. Methicillin-resistant Staphylococcus 
aureus was isolated in 3 patients (1.3%). Haemophilus influenzae was resistant 
to ampicillin in 22.2% cases in which it was the sole pathogen. 
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A 5-year review of the microbiology of acute 
complicated bacterial sinusitis at the University of the 
Witwatersrand 
 
 
INTRODUCTION 
Acute sinusitis defines a state in which there is rapid onset, progression and 
persistence of signs and symptoms caused by inflammatory disease within the 
paranasal sinuses. Viruses and bacteria are largely responsible for the 
development of acute sinusitis. Often an initial viral inflammation of the 
sinuses is superseded by invasion with a variety of bacterial pathogens and the 
development of complications at adjacent and/or remote sites. Management of 
acute complicated sinusitis requires an understanding of the anatomy of the 
sinuses and the microbiology of the associated pathogens. 
 
Embryology 
The paranasal sinuses are airspaces within the bones of the face and skull that 
are transposed as relations around the nasal cavity. There are four paired 
sinuses namely the maxillary, ethmoid, frontal and sphenoid sinuses. The 
paranasal sinuses develop as outpouches of the nasal cavity and remain in 
communication with the nasal cavity through narrow openings (or ostia). The 
maxillary and ethmoid sinuses are present at birth; the frontal and sphenoid 
sinuses begin to develop after the ages of 2 and 7 years, respectively. The 
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sinuses attain adult size between the age of 12 and 18, with the sphenoid sinus 
being the last to mature. 
 
Physiology 
The paranasal sinuses are lined with pseudostratified ciliated columnar 
epithelium which is in continuity with the mucosa of the nasal cavity. The 
epithelium also contains non-ciliated columnar cells, basal cells and mucus-
secreting goblet cells. The cilia in each sinus beat in a specific direction that 
results in orderly movement of mucus and debris around the sinus and 
ultimately through the sinus ostium and into the nasal cavity. 
 
Normally the paranasal sinuses are relatively sterile with low titers of bacteria 
of less than 1000 colony-forming units per milliliter of mucus. The sterility of 
the cavities is maintained in part by the mucociliary clearance system, the 
immune system of the body and nitric oxide production within the sinuses 
(Palm J, Lidman C, Graf P et al., 2000). Factors that prevent or delay the 
clearance of secretions from the paranasal sinuses result in the accumulation 
of secretions and subsequent colonization of the sinuses by pathogenic 
microorganisms by invasion from without and/or proliferation from within. 
 
Definitions 
Sinusitis describes a state in which pathogenic microorganisms colonize the 
mucosal lining of the paranasal sinuses and cause an inflammatory disorder. 
Viruses, bacteria, fungi and protozoa may cause the disease by infecting any 
one, or combination, of the sinuses. The term rhinosinusitis, used 
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interchangeably with the term sinusitis, depicts the disease state as a 
continuum of inflammation between the nasal and sinus mucosae. When 2 or 
more paranasal sinuses are simultaneously infected, the term pansinusitis is 
often used. Complications of paranasal sinus disease occur when the disease 
extends to involve bone, the adjacent orbit and cranial cavities and their 
respective contents. 
 
Treatment 
The mainstay of treatment of patients with sinusitis is medical and is directed 
towards alleviating the symptoms and eliminating the invading organism 
where possible. The treatment of sinusitis associated with complications 
constitutes both a medical and, in certain cases, a surgical emergency. 
 
At the University of the Witwatersrand’s ENT complex, patients with acute 
complicated sinusitis are referred to the department of Otorhinolaryngology 
usually when surgical intervention is anticipated. Prompt medical treatment 
with or without surgery must be initiated. This includes the use of antibiotics 
prior to obtaining laboratory identification of the offending pathogen(s). 
Observed differences in the local prevalence of bacterial pathogens and the 
continued emergence of antibiotic-resistant strains of bacteria influence the 
choice of antibiotic used to initiate treatment (Ali A, Kurien M, Mathews SS, 
Mathew J., 2005; Oxford LE, McClay J. 2005; Butler JC, Hofmann J, Cetron 
MS, Elliot JA, Facklam RR, Breiman RF.1996). 
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The decision to conduct this study is prompted by the need to know the 
prevalent bacteria associated with complicated sinusitis and their antibiotic 
sensitivity patterns as seen at the University of the Witwatersrand’s ENT 
complex. 
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LITERATURE REVIEW 
 
Bacterial sinusitis is a common disease of worldwide distribution that affects 
people of all ages. The course of the disease in patients with bacterial sinusitis 
is varied, ranging from mild and insidious to debilitating and potentially life-
threatening (Ali A, Kurien M, Mathews SS, Mathew J. 2005; Oxford LE, 
McClay J 2005). Bacterial sinusitis is usually preceded by an episode of viral 
sinusitis caused by viruses responsible for the common cold. These include 
such viruses as the adenovirus, rhinovirus, influenza virus, parainfluenza virus 
and respiratory syncytial virus. The resultant sinus mucosal inflammation 
causes oedema of the mucosa and obstruction of the sinus ostia and a 
concomitant reduction in ciliary action. 
 
It is classified into five clinical categories according to the duration of the 
signs and symptoms of disease and the frequency with which they occur 
(Piccirillo JF, 1998). These categories include: 
 
 Acute sinusitis in which symptoms and signs of the disease resolve completely 
and do not exceed 4 weeks duration, 
 Recurrent acute sinusitis in which 2 to 4 episodes of acute sinusitis occur per 
year with at least 8 weeks interval between each episode, 
 Subacute sinusitis in which symptoms of the disease persist for more than 4 
weeks but not beyond 12 weeks, 
 Chronic sinusitis in which insidious symptoms persist for over 12 weeks, 
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 Acute-on-chronic sinusitis in which a patient with chronic sinusitis 
experiences and acute exacerbation of symptoms. 
 
The presenting signs and symptoms in patients with sinusitis are those in 
keeping with an inflammatory disease of the upper respiratory tract. The 
findings include fever, headache, vomiting, nasal obstruction and discharge. 
When complications occur other more ominous signs occur, the clinical 
presentation being determined by the site and extent of the complications. 
Involvement of the orbit and brain would result in the development of features 
such as facial and periorbital swelling, proptosis, mood changes, seizures.  
 
Infection of the paranasal sinus is associated with serious complications as a 
result of the spread of the disease into adjacent and remote sites. Spread of the 
disease from the sinuses occurs through areas of osteitic bone destruction, 
congenital or acquired bony defects, or by way of septic thrombophlebitis of 
communicating veins (Osguthorpe JD, Hochman M, 1993). The complications 
of sinusitis fall into four categories namely orbital, intracranial, bone and soft 
tissue. The highest occurrence of complications of sinusitis is recorded in 
young male patients during the cold winter season (Oxford LE, McClay J, 
2002).  
 
Orbital complications are the most common complication of sinusitis (Ali A, 
Kurien M, Mathews SS, Mathew J, 2005; Oxford LE, McClay J, 2005; 
Schramm VL, Myers EN, Kennerdell JS, 1978), usually occurring as a result 
of ethmoid sinusitis (Arjmand EM, Lusck RP, Muntz HR, 1993). The 
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Chandler Classification describes 5 types of orbital complications (Chandler 
JR, Langenbrunner DJ, Stevens ER., 1970): 
 
 Preseptal cellulitis 
 Orbital cellulitis 
 Subperiosteal abscess 
 Orbital abscess 
 Cavernous sinus thrombosis 
 
In the pre-antibiotic error, permanent sequelae including blindness occurred in 
20% of patients with orbital complications (Gamble RC, 1933). Over the years 
incidence of permanent orbital complications has reduced to around 6-10.5% 
(Patt BS, Manning SC, 1991; Schramm VL, Myers EN, Kennerdell JS, 1978) 
with some centres now reporting incidences as low as 1.8% (Oxford LE, 
McClay J, 2005). 
 
Intracranial complications are most commonly secondary to acute frontal 
sinusitis and may include meningitis, cerebritis, epidural and subdural 
empyemas, cerebral abscess and thrombosis of venous sinuses (Ali A, Kurien 
M, Mathews SS, Mathew J. 2005; Clayman GL, Adams GL, Paugh DR et al 
1991; Oxford LE, McClay J. 2005; Remmler D, Boles R. 1980). With 
appropriate management the outcome of the disease will range from complete 
resolution to transient or permanent neurological deficit, seizures or even 
death (Younis RT, Lazar RH, 2002). 
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Bony complications include osteomyelitis of the frontal and maxillary sinus, 
frontal subperiosteal abscess and frontal pyocoele (Ali A, Kurien M, Mathews 
SS, Mathew J. 2005). 
 
Periorbital and facial cellulitis are the predominant soft tissue complications. 
 
The microbiology of bacterial sinusitis has been studied extensively in relation 
to the causative organisms. The invading bacterial pathogens, in both acute 
and chronic sinusitis, include a variety of aerobic, facultative and anaerobic 
organisms. The most common pathogens found in patients with acute bacterial 
sinusitis are aerobic and facultative anaerobes that include Streptococcus 
pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) 
catarrhalis (Brook, 2002; Brook I, Frazier EH, 2004; Jousimies-Somer HR, 
Savolainen S, Ylikoski JS, 1988; Tellez I, Alba LMD, Reyes MG, Patton E, 
Hesles H dl G., 2006). Anaerobic organisms, such as Propionbacterium acnes  
and Peptostreptococcus species, are found in as many as 31% of patients with 
acute bacterial sinusitis (Brook I, 2005). Isolates from patients with chronic 
sinusitis were found to have a mixture of both aerobic and anaerobic bacteria 
with a preponderance of anaerobic bacteria such as Prevotella species, 
Fusobacterium species, Peptostreptococcus species (Brook I, 1981). The 
aerobic bacteria isolated from patients with chronic sinusitis included 
Haemophilus influenzae, Staphylococcus aureus, Klebsiella pneumoniae and 
Pseudomonas aeruginosa (Brook I, 2002; Frederick J, Braude AI, 1974; 
Kamau JK, Macharia IM, Odhiambo PA, 2001). 
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Patients with bacterial pansinusitis are more likely to have a mixture of both 
aerobic and anaerobic bacteria. Furthermore a study on 155 patients with 
sinusitis demonstrated that the likelihood of anaerobic bacteria being present 
was significantly high when multiple sinuses were concurrently diseased 
(Brook I, 2004) 
 
There appears to be a different frequency pattern of bacteria isolated from 
patients with complicated sinusitis as compared to those presenting without 
complications. The profile of offending bacteria also differs in reports from 
different centres. Ali A et al (2005) isolated Staphylococcus aureus in 66.6% 
of patients. Other organisms cultured in this study included Enterobacter 
species, Streptococcus species, Protavella species and Bacteriodes. None of 
the isolates included Haemophilus influenzae and Moraxella catarrhalis. 
 
Special mention needs to be made of a group of streptococcal bacteria now 
known as the Streptococcus milleri group of bacteria. This group is made up 
of three species namely Streptococcus intermedius, Streptococcus consellatus 
and Streptococcus anginosus. Their role as pathogens human pathogens was 
not recognized until recently mainly because of difficulties in their laboratory 
identification and because of confusion surrounding their taxonomy and 
nomenclature (Ruoff KL, 1988). Oxford and McClay (2005) identified the 
Streptococcus milleri group of bacteria as being the most frequent bacteria 
isolated from children with complicated sinusitis. In their study ά-haemolytic 
Streptococci species, Staphylococcus aureus and Streptococcus pneumoniae 
followed in descending order of frequency. Haemophilus influenzae was 
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isolated from only one case, representing 0.9% of bacterial isolates. Moraxella 
catarrhalis was not found in this study. 
 
Acute sinusitis is extremely common and is the reason for which many 
patients seek medical attention. Most often the illness is of viral origin and 
about 2% of cases may become complicated by acute bacterial sinusitis (Lauer 
J, 2003). In the absence of obvious bacterial complications it is not possible to 
distinguish between viral and bacterial sinusitis on clinical grounds alone. 
Despite the knowledge that viral infections are the predominant cause of 
sinusitis many physicians continue to prescribe antibiotics as part of their first-
line of treatment (Gonzales R, Steiner JF, Sande MA., 1997). Over the years 
the use and abuse of antibiotics has led to the emergence of antibiotic-resistant 
strains of bacteria such a penicillin-resistant Streptococcus pneumoniae 
(Butler JC, Hofmann J, Cetron MS, Elliot JA, Facklam RR, Breiman RF, 
1996, Hofmann J, Cetron MS, Farley MM, Baughman WS, Facklam RR, 
Elliot JA et al., 1995), Methicillin-resistant Staphylococcus aureus  
and Pneumococci (Dowell SF, Schwartz B 1997; Kunin CM, 1993).  
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AIMS AND OBJECTIVE 
The aim of the study is to: 
 Describe the frequency of the types of microorganisms isolated from patients 
with acute complicated sinusitis at the teaching hospitals of the University of 
the Witwatersrand 
 Document the antibiotic susceptibility and resistance of the isolated 
microorganisms 
 Make recommendations on the choice of antibiotic to be used to initialize 
treatment prior to obtaining laboratory bacterial culture and sensitivity results.  
 
 
MATERIALS AND METHOD 
Ethics Approval 
This study was approved by the Standards and Ethics Committee of the 
University of the Witwatersrand. 
 
Study Location 
The study was conducted at the four university teaching hospitals namely 
Johannesburg General, Chris Hani Baragwanath, Helen Joseph and Coronation 
Hospitals. 
 
Study Period 
The study extended over a period of 5 years; starting from the 1st January 2002 
and ending on the 31st December 2006. 
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Study Population 
The study includes all patients who underwent paranasal sinus surgery as part 
of their management for acute complicated sinusitis and on whom sinus 
specimen microbiology analysis was performed.  
 
Data Collection 
Patients were identified from three sources within each hospital, namely the: 
 ENT and neurosurgery emergency theatre operation registers 
 ENT and neurosurgery ward admission registers 
 Radiology CT scan registers. 
 
The operating theatre emergency registers were used as the primary reference 
to identify patients who were recorded as having had sinus surgery as an 
emergency procedure. Both the ENT and neurosurgery registers were searched 
so as to include those patients with acute sinusitis who additionally suffered 
intracranial complications and may therefore have been registered as patients 
outside the ENT department. 
 
The ENT and neurosurgical ward admissions registers and the CT scan 
register were used as secondary references to aid in the identification of those 
patients whose information in the theatre register was unclear or lacking in 
details (e.g. missing or partial hospital numbers, misspelled names, illegible 
entry). These secondary references were also used as a screen to source for 
patients whose information may not have been identified specifically in the 
ENT and neurosurgery theatre registers. Those patients screened from this 
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secondary source included those who appeared in the ward register with a 
diagnosis of sinusitis and those in-patients, from any hospital ward, who 
appear in the CT scan register as having had a scan of either the paranasal 
sinuses or the brain with the orbit. 
 
All patients clearly identified from the theatre register were recorded as part of 
the initial sample population. The patients’ information was then used to 
search the database of the National Health Laboratory Service (NHLS) and all 
findings were recorded placed into one of the following six categories: 
 Positive cultures in which pathogenic microorganisms were identified 
 Negative cultures in which the report states that there was “no bacterial 
growth” 
 Histology reports in which a histological analysis but not a microbiological 
analysis was performed on the specimen 
 Rejected specimen in which the specimen received by the laboratory was 
unsuitable for processing 
 No results found in which no results were found in the database 
 Incomplete or incorrect information in which patients in the theatre register 
did not have sufficient information to interrogate the NHLS database 
 
Patients identified exclusively from the secondary references were cross-
checked against their recorded laboratory findings and were included in the 
study population only if certain conditions were met. These conditions for 
inclusion being that: 
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 There was a microbiology or histology laboratory report for the identified 
patient 
 The sample analysed was obtained from the paranasal sinuses 
 The report clearly stated that the sample was obtained from a patient with a 
history of acute complicated sinusitis 
 
Those patients selected from the secondary references who did not have 
sufficient information to search the NHLS database were not included in the 
study sample. 
 
The following data was recorded for each patient: 
 Full name 
 Age 
 Sex 
 Hospital registration number 
 Date of operation (specimen collection) 
 Type of operation / complication 
 Type of isolated microorganisms 
 Antibiotic sensitivity and resistance 
 
Laboratory results for microscopy culture and sensitivity were obtained at 
each hospital from the computer register of the resident NHLS laboratory. 
 
All data was recorded electronically using Microsoft Access database and 
Microsoft Excel Spreadsheet. 
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For the purposes of this study, only those patients who were identified as 
patients with acute complicated sinusitis, on whom sinus surgery was 
performed and, for whom positive microbiological cultures were obtained 
were included in the final study population and used for analysis. 
 
Data Analysis and Presentation 
Analysis of data was carried out by the MMed candidate (Dr IP Olwoch) at the 
Department of Otorhinolaryngology Head and Neck Surgery. Standard 
statistical methods are used. Student’s t test was used to analyse ordinal data 
and the Chi Square (X2) test was used for dichotomous nominal data. A 
probability (p) value of less than (or equal to) 0.05 is regarded as significant. 
 
The following software applications were used for data manipulation, 
statistical analysis and presentation: 
 Microsoft Access 2003 Database for data storage, retrieval and selection 
 Microsoft Excel 2003 Spreadsheet for descriptive data analysis, summary 
statistics and comparison of sample means 
 Web Chi Square Calculator (Ball CN, Connor-Linton J, 2007) for comparison 
of sample populations 
 Microsoft Word 2003 Word Processor for final documentation and 
presentation 
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Evaluation of data from identified microorganisms with respect to prevalence, 
age and gender of patients, and antibiotic sensitivity-resistance patterns was 
done. Special attention is given to comparative analysis of: 
 The bacterial profile in male patients as compared to female patients. 
 The bacterial profile in patients under the age of 15-years as compared to 
those over the age of 15 years. 
 The bacterial profile in those patients presenting with intracranial 
complications as compared to those without. 
 The bacterial profile in patients presenting at the different hospitals within the 
University ENT complex. 
 
 17
RESULTS 
 
A total of 301 patients were identified from the registers of the operating 
theatres, relevant wards and CT scan department (APPENDIX I) as patients 
who had undergone surgery for acute complicated sinusitis. The patients’ 
hospital admission numbers were used to search the NHLS database for 
records of microbiological investigations performed on specimens derived 
from their paranasal sinuses during the time of surgery. The findings were 
grouped into 6 categories (Table 1). 
 
Table 1: 
Categorization of microbiology culture results from 301 patients with acute 
complicated sinusitis. 
 
   
 Result category No. of patients 
1 Positive cultures 163 
2 Negative cultures 63 
3 No results found 42 
4 Incomplete information 3 
5 Histology report only 29 
6 Rejected specimen 1 
 TOTAL 301 
 
 
Rejected Patient Records 
75 patients, (Table 1: category 3-6), were rejected from the study sample and 
not included in any further discussion. 
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Study Population (n = 226) 
All patients in the study population underwent open sinus surgery by way of 
an external frontoethmoidectomy approach (or ethmoidectomy) with maxillary 
sinus puncture and washout. In addition 37 (16.4%) patients of the study 
population were diagnosed as having intracranial abscess formations. 13 of 
these patients underwent concurrent neurosurgical craniotomy for drainage of 
subdural empyema (n = 12) and brain abscess (n = 1). 
 
All specimens were collected intra-operatively and therefore standard aseptic 
conditions of collection are presumed to have been applied in all cases. 
Specimens were analysed at the respective hospitals by the resident NHLS 
laboratories in accordance with their Standard Operating Procedure Manual. 
Specimen derived from the sinuses as sinus aspirates (or tissues) are cultured 
aerobically at 35oC for 24 to 48 hours in: 
 5% horse blood agar 
 MacConkey agar 
 Chocolate agar 
 Thioglycolate broth 
and, anaerobically at 35oC for 24 to 48 in 10% horse blood agar and Amikacin 
blood agar. Direct gram staining and microscopy are performed after 24 hours. 
 
Both positive and negative microbiology culture records were obtained from 
226 patients (Table 1: category 1,2). Positive cultures were obtained in 163 
(72.1%) cases and 63 (27.9%) records were reported as having “no bacterial 
growth”. 
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Table 2 
Age and gender statistics of the study population. 
 
Statistic Value 
  
Mean 16.5 
Standard Error 0.7 
Median 14 
Mode 14 
Standard Deviation 10.1 
Sample Variance 101.8
Kurtosis 6.1 
Skewness 2.1
Range 73 
Minimum 1 
Maximum 74 
Count 226 
Male 159 
Female 67 
Male:Female 2.4:1 
 
 
 
Figure 1: 
Age distribution of 226 patients in the study population. 
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Analysis of negative cultures (n = 63) 
63 records out of 226 (Table 1: category 2), were reported to have had “no 
bacterial growth” thereby accounting for 27.9% of the obtained microbiology 
culture results. 
 
Table 3: 
Distribution of negative culture reports amongst 226 laboratory culture reports 
by gender, age and presence of neurosurgical complication. 
 
Group (n) 
Frequency 
of 
negative 
cultures 
% of total 
(n) 
Male (n = 159) 42 26.4 
Female (n = 67) 21 30.3 
Adult [>15 years] (n = 92) 23 23.9 
Paediatric [<1=15 years] 
(n = 133) 40 30.1 
Neurosurgical (n = 37) 6 16.2 
Non-neurosurgical (n = 188) 57 29.7 
   
 
There is no significant difference (X2 = 4.17 with 0 d.f., p>0.05) in the 
occurrance of negative culture results between the groups in Table 1. 
 
Negative culture reports are not included within the analysis of the reports 
with positive microbiological isolates. 
 
Analysis of  positive cultures (n = 163) 
163 patients with positive microbiological findings (Table 1: category 1) 
constituted 72.1% of the accepted study population. 
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The population of positive comprises of 163 laboratory results derived from 
117 male and 46 female patients consistent with a male to female ratio of 
2.5:1. The patients’ ages ranged from 3 to 74 years with a mean of 16.6 ± 0.8 
years. The greater percentage, 57.1%, of the population were under the age of 
16 years and 42.9% were 16 years and older. 
 
126 (77.3%) of patients were between the ages of 6 and 20 years of age with 
the highest incidence of 50 (30.7%) occurring in patients in the 11-15 year age 
group. 
 
Table 4: 
Age analysis of 163 patients in the positive culture population. 
 
Statistic Value 
  
Mean 16.6
Standard Error of Mean (s.e.m.) 0.8 
Median 14 
Mode 14 
Standard Deviation (s.d.) 10.1 
Sample Variance (V) 101.0 
Kurtosis 7.9 
Skewness 2.3 
Range (r) 71 
Minimum (min) 3 
Maximum(max) 74 
Count (n) 163 
Percentage of population (%) 100
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Figure 2: 
Age distribution of 163 patients in the positive culture population. 
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Table 5: 
233 bacteria and fungi isolated from 163 patients with acute complicated 
sinusitis expressed as raw data and percentage of total count. 
 
Microorganisms No. % Microorganisms No. % 
      
AEROBES   
FACULTATIVE 
ANAEROBES   
Gram positive cocci   Gram positive cocci   
Streptococcus milleri 43 18.5% Enterococcus durans 1 0.4% 
Group A β-haemolytic 
streptococci (S. pyogenes) 6 2.6% Gram positive bacilli   
Group C β-haemolytic 
streptococci 11 4.7% Lactobacillus species 1 0.4% 
Group F β-haemolytic 
streptococci 6 2.6% Gram negative bacilli   
Group G β-haemolytic 
streptococci 1 0.4% Eikenella corrodens 4 1.7% 
Streptococcus pneumoniae 6 2.6% Proteus mirabilis 1 0.4% 
Viridans streptococci 10 4.3% ANAEROBES   
Streptococcus species 12 5.2% Anaerobic cocci   
Staphylococcus aureus 29 12.4% Peptostreptococcus species 11 4.7% 
coagulase negative 
staphylococcus 20 8.6% Peptostreptococcus anaerobius 4 1.7% 
MRSA 3 1.3% Gram positive bacilli   
Staphylococcus species 3 1.3% Propionbacterium species 1 0.4% 
Gram negative cocci   Gram negative bacilli   
Moraxella catarrhalis 1 0.4% Prevotella species 11 4.7% 
Gram positive bacilli   Fusobacterium species 1 0.4% 
Corynebacterium species 4 1.7% Acinetobacter baumanii 1 0.4% 
Gram negative bacilli   Bacteroides species 1 0.4% 
Haemophilus influenzae 20 8.6% Photobacter species 1 0.4% 
Haemophilus 
parainfluenzae 2 0.9% FUNGI   
Haemophilus species 1 0.4% Candida glabrata 1 0.4% 
Escherichia coli 2 0.9% Sacchromyces cerevisiae 1 0.4% 
Klebsiella oxytoca 2 0.9% Yeast-like organisms 1 0.4% 
Klebsiella ozaenae 1 0.4% TOTAL 233 100.0% 
Klebsiella species 4 1.7% Summary:  
Enterobacter cloacae 2 0.9% Aerobes 192 82.4% 
Enterobacter faecalis 1 0.4% Facultative Anaerobes 7 3.0% 
Pseudomonas aeruginosa 1 0.4% Anaerobes 31 13.3% 
Citrobacter koserii 1 0.4% Fungi 3 1.3% 
      
 
The five most commonly isolated aerobic microorganisms are Streptococcus 
milleri, Staphylococcus aureus, β-haemolytic streptococci (A, C, F, and G), 
coagulase negative staphylococcus and Haemophilus influenzae.
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Table 6: 
 
Comparative analysis of the frequency of occurrence, of aerobes, facultative 
anaerobes, anaerobes and fungi in 163 patients with positive culture specimen 
 
 
Microorganism group 
 
Frequency 
 
% 
 
Aerobes only 127 77.9% 
Aerobes and Facultative 
Anaerobes 6 3.7% 
Aerobes and Anaerobes 19 11.7% 
Anaerobes only 8 4.9% 
Facultative Anaerobes only 1 0.6% 
Facultative Anaerobes and 
Anaerobes 0 0.0% 
Fungi 2 1.2% 
 
 
163 100.0% 
 
 
 
Table 7: 
 
Number of different microorganism species isolated per patient within the 
positive culture population (n = 163). 
 
 
No. of microorganism 
species per patient 
No. of patients Percentage of patient 
total (%) 
1 107 65.6 
2 43 26.4 
3 12 7.4 
4 1 0.6 
TOTAL: 163 100% 
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Table 8: 
 
107 bacteria and fungi species isolated as single pathogens from 107 patients 
with acute complicated sinusitis expressed as raw data and percentage of their 
total count (n = 107) 
 
Microorganism No. % Micoorganism No. % 
      
AEROBES   
FACULTATIVE 
ANAEROBES   
Gram positive cocci   Gram negative bacilli   
Streptococcus milleri 25 23.4% Eikenella corrodens 1 0.9% 
Group A β-haemolytic 
streptococci (S. pyogenes) 6 5.6% ANAEROBES  0.0% 
Group C β-haemolytic 
streptococci 5 4.7% Prevotella species 2 1.9% 
Group F β-haemolytic 
streptococci 6 5.6% 
Peptostreptococcus 
anaerobius 2 1.9% 
Streptococcus pneumoniae 3 2.8% Bacteroides species 1 0.9% 
Viridans streptococci 3 2.8% FUNGI  0.0% 
Streptococcus species 7 6.5% Yeast-like organisms 1 0.9% 
Staphylococcus aureus 16 15.0%    
coagulase negative 
staphylococcus 8 7.5% TOTAL: 107 100.0% 
MRSA 2 1.9%    
Staphylococcus species 2 1.9%    
Gram positive bacilli   Summary   
Corynebacterium species 3 2.8% Aerobes 100 93.5% 
Gram negative bacilli   Facultative anaerobes 1 0.9% 
Haemophilus influenzae 9 8.4% Anaerobes 5 4.7% 
Haemophilus parainfluenzae 1 0.9% Fungi 1 0.9% 
Klebsiella ozaenae 1 0.9%    
Klebsiella species 1 0.9%    
Enterobacter cloacae 2 1.9%    
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Table 9: 
 
86 microorganisms isolated as a pair of co-existing pathogens from 43 patients 
with acute complicated sinusitis expressed as raw data and percentage of their 
total count (n = 86) 
 
Microorganisms No. % Microorganisms No. % 
      
AEROBES   
FACULTATIVE 
ANAEROBES   
Gram positive cocci   Gram positive cocci   
Streptococcus milleri 13 15.1% Enterococcus durans 1 1.2% 
Group C β-haemolytic 
streptococci 6 7.0% Gram positive bacilli  0.0% 
Streptococcus pneumoniae 3 3.5% Lactobacillus species 1 1.2% 
Viridans streptococci 3 3.5% Gram negative bacilli  0.0%
Streptococcus species 4 4.7% Eikenella corrodens 2 2.3% 
Staphylococcus aureus 8 9.3% Proteus mirabilis 1 1.2%
coagulase negative 
staphylococcus 8 9.3% ANAEROBES  0.0% 
MRSA 1 1.2% Anaerobic cocci  0.0% 
Staphylococcus species 1 1.2% 
Peptostreptococcus 
anaerobius 2 2.3% 
Gram negative cocci  0.0% 
Peptostreptococcus 
species 9 10.5% 
Moraxella catarrhalis 1 1.2% Gram positive bacilli  0.0% 
Gram negative bacilli  0.0% 
Propionbacterium 
species 1 1.2% 
Haemophilus influenzae 8 9.3% Gram negative bacilli  0.0% 
Haemophilus species 1 1.2% Prevotella species 3 3.5% 
Escherichia coli 1 1.2% Fusobacterium species 1 1.2% 
Klebsiella oxytoca 1 1.2% 
Acinetobacter 
baumanii 1 1.2% 
Klebsiella species 2 2.3% FUNGI  0.0% 
Pseudomonas aeruginosa 1 1.2% Candida glabrata 1 1.2% 
 
Sacchromyces 
cerevisiae 1 1.2% 
 TOTAL: 86 100.0% 
 Summary   
 Aerobes 62 72.1% 
 
Facultative 
anaerobes 5 5.8%
 Anaerobes 17 19.8% 
 Fungi 2 2.3%
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Table 10: 
40 microorganisms isolated as multiple pathogens in 13 patients with acute 
complicated sinusitis caused by three or more different microorganisms 
expressed as raw data and percentage of their total count (n = 40) 
 
Microorganism No. % Microorganism No. % 
    
AEROBES 
FACULTATIVE 
ANAEROBES   
Gram positive cocci 
Gram negative 
bacilli   
Streptococcus milleri 5 12.5% 
Eikenella 
corrodens 1 2.5% 
Group G β-haemolytic 
streptococci 1 2.5% ANAEROBES   
Viridans streptococci 4 10.0% Anaerobic cocci   
Streptococcus species 1 2.5%
Peptostreptococcus 
species 2 5.0%
Staphylococcus aureus 5 12.5% 
Gram negative 
bacilli   
coagulase negative 
staphylococcus 4 10.0% Prevotella species 6 15.0% 
Gram positive bacilli 
Photobacter 
species 1 2.5% 
Corynebacterium species 1 2.5%    
Gram negative bacilli    
Haemophilus influenzae 3 7.5% TOTAL: 40 100.0% 
Haemophilus 
parainfluenzae 1 2.5%    
Escherichia coli 1 2.5% Summary   
Klebsiella oxytoca 1 2.5% Aerobes 30 75.0% 
Klebsiella species 1 2.5% 
Facultative 
Anaerobes 1 2.5% 
Enterobacter faecalis 1 2.5% Anaerobes 9 22.5% 
Citrobacter koserii 1 2.5% Fungi 0 0.0% 
      
 
12 patients had three pathogens isolated from their sinus specimen and 1 
patient had 4 pathogens. 
 
The single patient from who 4 pathogens were isolated was found to have 
Streptococcus milleri, Viridans streptococci, Haemophillus influenzae and 
Photobacter species. 
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Table 11: 
 
Comparative analysis of the frequency of occurrence of microorganisms 
between groups of patients with different numbers of microorganism species 
identified. 
 
No. of 
microorganisms 
per patient 
Aerobes Facultative 
Anaerobes 
Anaerobes Fungi Total 
1 100 1 5 1 107 
2 62 5 17 2 86 
3 27 1 8 0 36 
4 3 0 1 0 4 
 192 7 31 3 233 
 
 
Comparative analysis of the relative distribution of aerobes, facultative 
anaerobes, anaerobes and fungi between the four groups of patients was made 
using the Chi Squared Distribution. A highly significant difference (3 d.f. X2 = 
18.5, p<0.05) was noted. 
 
Distribution of aerobes and anerobes in monomicrobial verses polymicrobial 
isolates 
There is a significant difference (p<0.05) in the pattern of distribution of 
aerobic and anaerobic microorganisms between the mono and polymicrobial 
patient groups. This is most likely attributed to the high proportion of: 
 aerobic microorganisms in patients where a single species was isolated 
 anaerobic microorganisms in the polymicrobial isolates 
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Patients with monomicrobial isolates accounted for 107 of 163 (65.4%) of the 
positive culture population whilst patients with polymicrobial isolates 
accounted for the remaining 56 of 163 (34.6%). 
 
 
Table 12: 
 
Comparison of age and age distribution between 117 male and 46 female 
patients in the positive culture population. 
 
Statistic Male Female 
   
Mean 15.6 19.1 
Standard Error 0.7 2.1 
Median 14 15.5 
Mode 14 13 
Standard Deviation 7.7 14.2 
Sample Variance 59.3 201.9 
Kurtosis 3.8 4.5 
Skewness 1.8 1.9 
Range 44 71 
Minimum 4 3 
Maximum 48 74 
Count 117 46 
Percentage of total 71.8% 28.2% 
   
 
 
Analysis of the mean age of the male and female patients was done with 
Student’s t-test for comparison of the two sample means with unequal 
variances. This showed no significant difference (t = 1.58, p>0.05) between 
the mean ages of male and female patients. 
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Table 13: 
 
Comparative distribution of microorganisms by patients’ gender of 234 
microbiological isolates from 117 male and 46 female patients. 
 
     
Microorganism Male Female Microorganism Male Female 
      
AEROBES   FACULTATIVE ANAEROBES  
Gram positive cocci   Gram positive cocci   
Streptococcus milleri 32 11 Enterococcus durans 1 0 
Group A β-haemolytic 
streptococci (S. pyogenes) 2 4 Gram positive bacilli   
Group C β-haemolytic 
streptococci 10 1 Lactobacillus species 1 0 
Group F β-haemolytic 
streptococci 3 3 Gram negative bacilli   
Group G β-haemolytic 
streptococci 1 0 Eikenella corrodens 3 1 
Streptococcus pneumoniae 5 1 Proteus mirabilis 1 0 
Viridans streptococci 9 1 ANAEROBES   
Streptococcus species 10 2 Anaerobic cocci   
Staphylococcus aureus 18 11 Peptostreptococcus species 8 3 
coagulase negative 
staphylococcus 15 5 
Peptostreptococcus 
anaerobius 4 0 
MRSA 2 1 Gram positive bacilli   
Staphylococcus species 3 0 Propionbacterium species 1 0 
Gram negative cocci Gram negative bacilli  
Moraxella catarrhalis 1 0 Prevotella species 8 3 
Gram positive bacilli Fusobacterium species 1 0
Corynebacterium species 3 1 Acinetobacter baumanii 0 1 
Gram negative bacilli   Bacteroides species 0 1 
Haemophilus influenzae 14 6 Photobacter species 1 0 
Haemophilus parainfluenzae 2 0 FUNGI   
Haemophilus species 1 0 Candida glabrata 1 0 
Escherichia coli 1 1 Sacchromyces cerevisiae 1 0 
Klebsiella oxytoca 2 0 Yeast-like organisms 0 1 
Klebsiella ozaenae 0 1    
Klebsiella species 3 1 TOTAL: 170 63 
Enterobacter cloacae 2 0    
Enterobacter faecalis 0 1 Summary:   
Pseudomonas aeruginosa 0 1 Aerobes 139 52 
Citrobacter koserii 1 0 Facultative Anaerobes 6 1 
   Anaerobes 23 9 
  Fungi 2 1 
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Comparison of the relative distribution of aerobes, facultative anaerobes, 
anaerobes and fungi between male and female patients (Table 13) showed no 
significant difference (X2 = 0.62, d.f. = 2, p>0.05) between the two groups. 
 
The frequencies of the five most commonly isolated aerobic microorganisms 
(refer to page 23) are compared between the male and female patients and are 
shown to have no significant difference (X2 = 1.6, d.f = 4, p>0.05).  
 
The frequencies of Peptostreptococcus and Prevotella species showed no 
significant difference (X2 = 0.2, d.f = 1, p>0.05) between male and female 
patients.
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Table 14: 
 
Comparison of age and age distribution between paediatric (<= 15 years) and 
adult (> 15 years) patients in the positive culture population. 
 
 
Statistic <= 15 years > 15 years 
   
Mean 10.8 24.2 
Standard Error 0.3 1.3 
Median 11 19 
Mode 14 17 
Standard Deviation 3.1 10.9 
Sample Variance 9.8 119.8 
Kurtosis -0.2 5.8 
Range 12 58 
Minimum 3 16 
Maximum 15 74 
Count 93 70 
Percentage of total 57.1% 42.9% 
   
 
 
The difference between the mean ages of the paediatric and adult populations 
is significant (t = -11.24, d.f. = 161, p<0.05).  
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Table 15: 
 
Comparative distribution of microorganisms by patients’ age in 234 
microbiological isolates from 93 paediatric (<= 15 years) and 70 adult (> 15 
years) patients. 
 
Microorganism <=15 >15 Microorganism <=15 >15 
    
AEROBES   FACULTATIVE ANAEROBES 
Gram positive cocci   Gram positive cocci 
Streptococcus milleri 28 15 Enterococcus durans 0 1 
Group A β-haemolytic 
streptococci (S. pyogenes) 3 3 Gram positive bacilli 
Group C β-haemolytic 
streptococci 3 8 Lactobacillus species 0 1 
Group F β-haemolytic 
streptococci 5 1 Gram negative bacilli 
Group G β-haemolytic 
streptococci 0 1 Eikenella corrodens 4 0 
Streptococcus pneumoniae 6 0 Proteus mirabilis 0 1 
Viridans streptococci 5 5  
Streptococcus species 9 3 ANAEROBES 
Staphylococcus aureus 18 11 Anaerobic cocci 
coagulase negative 
staphylococcus 6 14 Peptostreptococcus species 9 2 
MRSA 2 1 Peptostreptococcus anaerobius 1 3 
Staphylococcus species 0 3 Gram positive bacilli 
Gram negative cocci   Propionbacterium species 1 0 
Moraxella catarrhalis 1 0 Gram negative bacilli 
Gram positive bacilli   Prevotella species 7 4 
Corynebacterium species 1 3 Fusobacterium species 1 0 
Gram negative bacilli   Acinetobacter baumanii 1 0 
Haemophilus influenzae 15 5 Bacteroides species 1 0 
Haemophilus parainfluenzae 2 0 Photobacter species 1 0 
Haemophilus species 1 0    
Escherichia coli 0 2 FUNGI   
Klebsiella oxytoca 0 2 Candida glabrata 0 1 
Klebsiella ozaenae 0 1 Sacchromyces cerevisiae 0 1 
Klebsiella species 0 4 Yeast-like organisms 0 1 
Enterobacter cloacae 2 0    
Enterobacter faecalis 0 1 TOTAL 133 100 
Pseudomonas aeruginosa 0 1  
Citrobacter koserii 0 1 Summary: 
 Aerobes 107 85 
   Facultative Anaerobes 4 3 
   Anaerobes 22 9 
   Fungi 0 3 
     
 
 34
Comparison of the relative distribution of aerobes, facultative anaerobes, 
anaerobes and fungi between paediatric and adult patients (Table 15) showed 
no significant difference (X2 = 0.95, d.f. = 2, p>0.05) between the two groups. 
 
The frequencies of the five most commonly isolated aerobic microorganisms 
(refer to page 23) are compared between the paediatric and adult patients and 
are shown to be significantly different (X2 = 11.3, d.f. = 4, p<0.05). 
 
Haemophilus influenzae is significantly more common (p<0.05) amongst the 
paediatric patients and coagulase negative staphylococcus is more common 
(p<0.05) amongst the adult patients. 
 
There is no significant difference in the frequencies of occurrance of 
Streptococcus milleri, Staphylococcus aureus, β-haemolytic streptococci (A, 
C, F, and G) between the adult and paediatric groups.  
 
The frequencies of Peptostreptococcus and Prevotella species showed no 
significant difference (X2 = 0.03, d.f = 1, p>0.05) between the two groups. 
 
 35
Table 16: 
 
Comparative analysis of age, age distribution and population size between 
patients presenting with intracranial complications and those without 
intracranial complications. 
 
 
Statistic 
 
Intracranial Complications 
 
 YES NO 
Mean 13.2 17.4 
Standard Error 0.5 1 
Median 13 15 
Mode 10 9 
Standard Deviation 2.9 10.9 
Sample Variance 8.3 119.8 
Kurtosis 0 6 
Skewness 0.6 2 
Range 12 71 
Minimum 8 3 
Maximum 20 74 
Count 31 132 
Percentage of total  19.0 % 81.0 % 
  
 
 
No significant difference (t = -3.82, d.f. = 159, p>0.05) is noted between the 
mean age and age distribution of the patients presenting with additional 
intracranial complications and those without intracranial complications. 
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Table 17: 
 
Comparative distribution of microorganisms isolated from 31 patients with 
intracranial complications as compared to 132 patients without intracranial 
complications. 
 
Microorganism 
Intracranial 
complication Microorganism 
Intracranial 
complication 
  YES NO   YES NO 
AEROBES  FACULTATIVE ANAEROBES 
Gram positive cocci Gram positive cocci 
Streptococcus milleri 15 28 Enterococcus durans 0 1 
Group A β-haemolytic 
streptococci (S. pyogenes) 1 5 Gram positive bacilli 
Group C β-haemolytic 
streptococci 3 8 Lactobacillus species 0 1 
Group F β-haemolytic 
streptococci 1 5 Gram negative bacilli 
Group G β-haemolytic 
streptococci 0 1 Eikenella corrodens 2 2 
Streptococcus 
pneumoniae 0 6 Proteus mirabilis 0 1 
Viridans streptococci 3 7 ANAEROBES  
Streptococcus species 2 10 Anaerobic cocci  
Staphylococcus aureus 3 26 Peptostreptococcus species 5 6 
coagulase negative 
staphylococcus 4 16 
Peptostreptococcus 
anaerobius 0 4 
MRSA 2 1 Gram positive bacilli 
Staphylococcus species 0 3 Propionbacterium species 0 1 
Gram negative cocci Gram negative bacilli 
Moraxella catarrhalis 0 1 Prevotella species 5 6 
Gram positive bacilli 0 Fusobacterium species 0 1 
Corynebacterium species 0 4 Acinetobacter baumanii 0 1 
Gram negative bacilli Bacteroides species 0 1 
Haemophilus influenzae 4 16 Photobacter species 1 0 
Haemophilus 
parainfluenzae 0 2 FUNGI  
Haemophilus species 0 1 Candida glabrata 0 1 
Escherichia coli 0 2 Sacchromyces cerevisiae 0 1
Klebsiella oxytoca 1 1 Yeast-like organisms 0 1 
Klebsiella ozaenae 0 1 TOTAL: 53 180 
Klebsiella species 1 3 Summary:   
Enterobacter cloacae 0 2 Aerobes 40 152 
Enterobacter faecalis 0 1 Facultative Anaerobes 2 1 
Pseudomonas aeruginosa 0 1 Anaerobes 11 20 
Citrobacter koserii 0 1 Fungi 0 3 
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Comparison of the relative distribution of aerobes, facultative anaerobes, 
anaerobes and fungi isolated from those patients with intracranial 
complications and those without (Table 17) showed no significant difference 
(X2 = 5.39, d.f. = 2, p>0.05) between the two groups. 
 
The frequencies of the five most commonly isolated aerobic microorganisms 
(refer to page 23) are compared between the neurosurgical and non-
neurosurgical patients and are shown to have no significant difference (X2 = 
6.4, d.f = 4, p>0.05).  
 
The frequencies of Peptostreptococcus and Prevotella species showed no 
significant difference (X2 = 0.4, d.f = 1, p>0.05) between the two groups. 
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Table: 18 
 
Comparative analysis of age, age distribution and population size between 
patients presenting at the Johannesburg Hospital (JH) and those at Chris Hani 
Baragwanath Hospital (CHB). 
 
 
Statistic JH CHB 
   
Mean 18.4 15.3 
Standard Error 1.2 1.0 
Median 17 13 
Mode 9 14 
Standard Deviation 10.0 10.0 
Sample Variance 99.9 99.8 
Kurtosis 1.3 14.8 
Skewness 1.3 3.3 
Range 45 71 
Minimum 3 3 
Maximum 48 74 
Count 69 93 
 
 
There is no significant difference (t = -1.96, d.f = 147, p>0.05) between the 
mean age and age distribution of the patients presenting at the two main 
hospitals. 
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Table: 19 
 
Comparative distribution of microorganisms between 69 patients at 
Johannesburg General Hospital (JH) and 93 patients at Chris Hani 
Baragwanath Hospital (CHB). 
 
   
Microorganisms JH CHB Microorganisms JH CHB 
            
AEROBES   
FACULTATIVE 
ANAEROBES   
Gram positive cocci Gram positive cocci  
Streptococcus milleri 2 41 Enterococcus durans 1 0 
Group A β-haemolytic streptococci 
(S. pyogenes) 4 2 Gram positive bacilli   
Group C β-haemolytic streptococci 8 4 Lactobacillus species 1 0 
Group F β-haemolytic streptococci 5 1 Gram negative bacilli   
Group G β-haemolytic streptococci 1 0 Eikenella corrodens 0 4 
Streptococcus pneumoniae 0 6 Proteus mirabilis 0 1 
Viridans streptococci 4 6 ANAEROBES   
Streptococcus species 11 1 Anaerobic cocci   
Staphylococcus aureus 10 19 
Peptostreptococcus 
species 1 10 
coagulase negative staphylococcus 13 6 
Peptostreptococcus 
anaerobius 4 0 
MRSA 0 3 Gram positive bacilli   
Staphylococcus species 3 0
Propionbacterium 
species 1 0
Gram negative cocci   Gram negative bacilli   
Moraxella catarrhalis 0 1 Prevotella species 1 10
Gram positive bacilli   Fusobacterium species 1 0 
Corynebacterium species 3 1 Acinetobacter baumanii 0 1 
Gram negative bacilli   Bacteroides species 1 0 
Haemophilus influenzae 7 13 Photobacter species 0 1 
Haemophilus parainfluenzae 1 1 FUNGI   
Haemophilus species 0 1 Candida glabrata 1 0 
Escherichia coli 0 2 Sacchromyces cerevisiae 1 0 
Klebsiella oxytoca 1 1 Yeast-like organisms 1 0
Klebsiella ozaenae 0 1 TOTAL 88 145 
Klebsiella species 1 3 Summary:   
Enterobacter cloacae 0 2 Aerobes 74 118 
Enterobacter faecalis 0 1 Facultative Anaerobes 2 5
Pseudomonas aeruginosa 0 1 Anaerobes 9 22 
Citrobacter koserii 0 1 Fungi 3 0 
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Comparison of the relative distribution of aerobes, facultative anaerobes, 
anaerobes and fungi isolated from patients at Johannesburg General Hospital 
with those from Chris Hani Baragwanath Hospital (Table 19) showed no 
significant difference (X2 = 0.47, d.f. = 1, p>0.05) between the two groups. 
 
The frequencies of the five most commonly isolated aerobic microorganisms 
are compared between patients at the two hospitals (Table 19). The study 
shows a significant difference (X2 = 40.7, d.f = 4, p<0.05) between common 
organisms the Chris Hani Baragwanath Hospital and Johannesburg Hospital. 
 
The frequencies of isolation of Streptococcus milleri and Haemophilus 
influenzae are significantly higher (p<0.05) at the Chris Hani Baragwanath 
Hospital (Table 19). 
 
The frequencies of isolation of β-haemolytic streptococci (group A, C, G and 
F) and coagulase negative staphylococcus are significantly higher (p<0.05) at 
the Johannesburg Hospital. The frequency of isolation of Streptococcus milleri 
at the Johannesburg Hospital is low (p<0.05). 
 
There is no significant difference (p>0.05) in the frequencies of occurrance of 
Staphylococcus aureus at the two main hospitals (Table 19). 
 
The frequencies of Peptostreptococcus and Prevotella species at the two 
hospitals (Table 19) showed no significant difference (X2 = 2.1, d.f. = 1, 
p>0.05). 
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Antibiotic Susceptibility and Resistance Patterns (APPENDIX II) 
 
Antibiotic sensitivity and resistance patterns were documented for 129 patients 
in the positive culture population. 
 
Table 20: 
  
Recorded incidence of antibiotic sensitivity of some common pathogens 
isolated from monomicrobial specimen. 
 
Microorganism 
 
No. of 
test 
results 
Antibiotic 
Penicillin 
 
 
 
Ampicillin 
 
 
Cloxacillin 
 
 
Erythrom
ycin 
Streptococcus 
milleri 25 84.0% 
   
Anaerobes 0 - - - - 
Staphylococcus 
aureus 16 6.3% 
- 93.8% 62.5% 
β-haemolytic 
streptococci 
(A,C,F,G) 11 90.9% 
 
90.9% 
- - 
coagulase 
negative 
staphylococcus 1 - 
 
- 
 
100% 
 
100% 
Haemophilus 
influenzae 18  
66.7%   
Streptococcal 
species 3 100% 
100%  100% 
Streptococcus 
pneumoniae 2 100% 
 
- 
 
- 
 
- 
others (22 
microorganism 
species)   
Viridans 
streptococci 2 
Reported as being susceptible to Cefotaxime, 
Ceftriaxone Vancomycin, Linezolid 
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Table 21 
 
Profile of the distribution of Streptococcus milleri and other bacteria in 43 
patients from the study population. 
 
No.  Accompanying Microorganisms
1 Streptococcus milleri Haemophilus influenzae
2 Streptococcus milleri   
3 Streptococcus milleri MRSA 
4 Streptococcus milleri   
5 Streptococcus milleri   
6 Streptococcus milleri   
7 Streptococcus milleri   
8 Streptococcus milleri Klebsiella species 
9 Streptococcus milleri   
10 Streptococcus milleri   
11 Streptococcus milleri   
12 Streptococcus milleri   
13 Streptococcus milleri
14 Streptococcus milleri Staphylococcus aureus 
15 Streptococcus milleri Peptostreptococcus species
16 Streptococcus milleri Eikenella corrodens 
17 Streptococcus milleri   
18 Streptococcus milleri Staphylococcus aureus 
19 Streptococcus milleri Eikenella corrodens 
20 Streptococcus milleri   
21 Streptococcus milleri   
22 Streptococcus milleri   
23 Streptococcus milleri   
24 Streptococcus milleri   
25 Streptococcus milleri   
26 Streptococcus milleri Prevotella species, Peptostreptococcus species 
27 Streptococcus milleri Prevotella species
28 Streptococcus milleri   
29 
Streptococcus milleri 
Viridans streptococci, Prevotella species, 
Haemophilus influenzae 
30 Streptococcus milleri   
31 Streptococcus milleri   
32 Streptococcus milleri
33 Streptococcus milleri Peptostreptococcus species 
34 Streptococcus milleri
35 Streptococcus milleri   
36 Streptococcus milleri coagulase negative staphylococcus 
37 Streptococcus milleri Escherichia coli, Klebsiella species 
38 
Streptococcus milleri 
coagulase negative staphylococcus, 
Peptostreptococcus species 
39 Streptococcus milleri Viridans streptococci, Prevotella species 
40 Streptococcus milleri coagulase negative staphylococcus 
41 Streptococcus milleri Acinetobacter baumanii 
42 Streptococcus milleri   
43 Streptococcus milleri   
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Table 22: 
General profile of antibiotic resistance: Antibiotic and antibiotic groups 
recorded against the number of recorded instances of microbial resistance. 
 
Antimicrobial Agent 
No. of 
cases 
  
Cephalosporins 14 
     1st Cefazolin, Cephaliexin  
     2nd Cefuroxime  
     3rd Ceftiaxone, Cefotaxime, Ceftazidime  
Macrolides (Erythromycin) 6 
Tetracyclines (Tetracycline) 2 
Aminoglycosides (Amikacin, Gentamicin, Rifampicin, Tobramycin) 4 
Lincosamides (Clindamycin) 4 
Cotrimoxazole 9 
Chloramphenicol 1 
Penicillins (Penicillin,Ampicillin, Amoxycillin, Cloxacillin, Co-
amoxiclav, Piperacillin-Tazobactam) 72 
  
TOTAL: 112 
  
 
 
Resistance to the penicillins as a group of drugs was encountered in 64.3% of 
cases with resistance to penicillin alone accounting for 41 (36.6%) of cases. 
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DISCUSSION 
 
In this study we analysed the microbiology findings from 266 patients selected 
from a pool of 301 who were diagnosed with acute complicated sinusitis 
(Table 1). The mean age of the patient pool was 16.5 (± 0.7) years. The 
patients were predominantly male with a male: female ratio of 2.4:1 (Table 2). 
A peak incidence of 73 (32.3 %) occurred in paediatric patients aged 11-15 
years with the next highest of 27.4% (62) being in adolescents and young 
adults aged 16-20 years (Figure 1). 
 
All patients in this study underwent open sinus surgery as part of their 
management during which procedure sinus aspirates and tissues were derived 
for microbiological analysis. We found positive cultures in 163 (72.1%) of 
cases and negative cultures in 63 (27.9%) of cases which is within the range 
(20-33.3%) noted other studies (Penttila M et al 1997; Mortimore et al 1998; 
Ali et al 2005). No significant trends (p>0.05) in the occurrance of negative 
culture results could be established between the patients on the basis of age, 
gender or neurosurgical complication. However, those with neurosurgical 
complications appeared to have a slightly lower percentage of negative 
microbiology cultures at 16.2% (Table 3). 
 
A total of 233 microorganisms were identified from 163 patients (an average 
of 1.4 isolates per specimen) with positive microbiology culture results (Table 
5). Aerobic and facultative anaerobes accounted for 199 (85.4%) of the 
isolates whilst anaerobes accounted for 31 (13.3%). Two specimens were 
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found to have fungal growths and no bacteria and accounted for 3 (1.3%) of 
the positive isolates. 
 
When the data is viewed from the perspective of the patient, 134 (82.0%) 
patients had aerobes and/or facultative anaerobes, 19 (11.7%) patients had 
both aerobic and anaerobic isolates, 8 (4.9 %) had only anaerobic species and 
2 (1.3%) had fungi isolated from their sinus specimen (Table 6). It may also 
suffice to say that 27 (16.6%) of the patients with positive isolates had 
anaerobes with or without the concurrent presence of aerobes.  
 
The bacteriology of acute sinusitis has been extensively studied. Many reports 
in medical literature mention the common aerobic microorganisms in acute 
sinusitis as being Streptococcus pneumonia, Haemophilus influenzae and 
Moraxella catarhalis (Wald et al 1981; Snyman et al 1988; Wald 1992; 
Penttilla et al 1997; Jousimies-Somer et al 1988; Brook 2002; Brook, Frazier 
2004; Brook 2005(b); Tellez et al 2006). Stapylococcus aureus and anerobic 
bacteria are given greater recognition as pathogens in chronic sinusitis 
(Ramadan H 1995, Brook I, 2002; Frederick J, Braude AI, 1974; Kamau at al 
2001; Wald 1992; Brook 2005(b)). However, there are also reports that 
highlight Staphylococcus aureus as an important pathogen in acute sinusitis 
(Hnatuk LAP et al 1994). It is worth noting that all these studies differ from 
this study in that they were conducted on patients who did not have severe 
disease associated with complications. 
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In this study Streptococcus milleri was the most frequently isolated 
microorganism accounting for 43 (18.5 %) isolates. Only recently has 
Streptococcus milleri been recognized as a human pathogen accounting for its 
absence in earlier reports (Ruoff KL, 1988). Next in descending order of 
frequency were Staphylococcus aureus 29 (12.4%), β-haemolytic streptococci 
24 (10.8%), coagulase negative staphylococcus 20 (8.6%) and Haemphilus 
influenzae 20 (8.6%).  Streptococcus pneumoniae accounted for only 6 (2.6%) 
of the isolates and only one isolate containing Moraxella catarrhalis (0.4%) 
was identified.  
 
Four retrospective studies on the bacteriology of acute complicated sinusitis, 
were conducted on a study population with a similar profile to this study. Two 
studies (Mortimore S, Wormald PJ, Oliver S. 1998; Oxford LE, McClay J. 
2005) found Streptococcus milleri to be the most frequently isolated 
microorganism and concurred with the findings of this study. In their patients 
with orbital and intracranial complications, Mortimore et al (1998) similarly 
observed that Staphylococcus aureus (25%) was the next most frequent 
isolate, that there was a low frequency of Streptococcus pneumoniae (4%) and 
Moraxella catarrhalis (0.0%) was notably absent. Oxford and McClay (2005) 
ranked Staphylococcus aureus and coagulase negative staphylococci third and 
fourth respectively. The two other studies (Rosenfeld EA 1993, Ali et al 2005) 
both identified Staphylococcus aureus and anaerobes as the predominant 
isolates. 
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Anaerobic bacteria are generally associated with chronic sinusitis. 
Peptostreptococci, Prevotella, Fusobacterium, Propionbacterium and 
Bacteroides are the anaerobes most frequently encountered and reported in 
many articles (Ramadan H 1995, Brook 1981, 2002, 2004). There does not 
appear to be any consistent pattern in the order of frequency with which they 
appear. Anaerobes were isolated 31 times (13.3%) in this study, and the most 
frequently isolated anaerobes were Peptostreptococci 15 (6.4%) and 
Prevotella species 11 (4.7%). Similarly Brook (2005) isolated 
Peptostreptococci in 4 (8.5%) of patients with acute sinusitis. Oxford and 
McClay (2004) reported an 18.6% occurrance of anaerobes and identified 
Prevotella 4 (8.3%) and Bacteroides 2 (4.2%) species as the most common. 
Similarly Ali et al (2005) isolated Prevotella 1 (8.3%) and Bacteroides 
(8.3%). A study on children with intracranial abscesses (Rosenfeld E, Rowley 
1993) isolated Bacteroides species in 3 out of 4 positive culture specimens. 
Mortimore et al (1998) reported a much lower frequency of 1.6% of anaerobes 
and made no mention of the identity of the species. The pattern of anaerobes 
encountered in this study closely resembles that seen in patients with chronic 
sinusitis. 
 
Monomicrobial and Polymicrobial Isolates 
Brook 2004 demonstrated the distribution of microorganisms between the 
various sinuses was not uniform with the possibility of some sinuses being 
free of pathogens. The number of isolates within each positive culture 
specimen varied (Table 7). Single microbial species were isolated from 107 
(65.6%) specimen whilst polymicrobial isolates, numbering 2 to 4 species per 
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specimen, were found in 56 (34.4%) of cases. Those patients with 
monomicrobial isolates had a significantly (p<0.05) higher proportion of 
aerobic isolates than those with polymicrobial isolates. Polymicrobial isolates 
were found to be associated with a significantly higher (p<0.05) occurrance of 
anaerobic microorganisms (Tables 8, 9, 10, 11). Polymicrobial specimen and 
the prominence of anaerobes suggests the presence of chronic disease 
(Ramadan H 1995, Brook 1981, 2002, 2004). 
 
Male and Female Patients 
There was no significant difference (p>0.05) between male and female 
patients in the relative distribution of aerobes, facultative anaerobes, anaerobes 
and fungi (Table 13). There are no studies which suggest there is any 
difference in the microbiology of sinusitis between male and female patients. 
 
Paediatric and Adult Populations 
93 (57.1%) of the study population were 15 years and younger (Table 15). No 
statistically significant difference (p>0.05) was shown between paediatric and 
adult patients in the relative distribution of aerobes, facultative anaerobes, 
anaerobes and fungi.  
There was a difference in the priority order of the frequency of occurrence of 
aerobic bacteria in the paediatric patients. Streptococcus milleri (21.1%, n = 
28) and Staphylococcus aureus (13.5%, n = 18) remained in the top two 
positions with the third and fourth positions being occupied by Haemophilus 
influenzae (11.3%, n = 15) and β-haemolytic streptococci (8.3%, n =11). In 
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the adult patients the frequent aerobes were the same as those common to the 
whole patient population. 
Haemophilus influenzae occurred more frequently (p<0.05) in the paediatric 
group (11.3%, n = 15) as compared to the adult group (5.0%, n = 5). Two 
studies within the same region (Snyman et al 1988, Mortimore et al 1998) find 
a higher frequencies of Haemophilus influenzae, in 6 (22.2%) and 9 (16.0%) 
of isolates, as compared either age group in this study. 
On the other hand coagulase negative staphylococcus occurred more 
frequently (p<0.05) in the adult patients (14.0%, n = 14) than in the paediatric 
patients (4.5%, n = 6).  Moraxella catarrhalis was identified in one (0.8%) 
isolate in the paediatric group in contrast to other studies (Penttilla et al 1997, 
Wald et al 1981, Brook et al 2005b, Tellez et al 2006) that show Moraxella 
catarrhalis to be an important pathogen in children and adults. 
 
Neurosurgical and Non-neurosurgical Cases 
There was no significant difference (p>0.05) between in the relative 
distribution of aerobes, facultative anaerobes, anaerobes and fungi in patients 
with intracranial complications as compared to those without such 
complications (Table 17). 
 
There were three observations worth noting from the comparative analysis of 
patients with intracranial complications. This study finds Streptococcus milleri 
to be the predominant pathogen in patients with intracranial complications. 
This finding is also reported by Mortimore et al (1998) and Oxford and 
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McClay (2005). The second is that anaerobes account for 20.8% (n = 11) of 
the isolates from patients with intracranial complications as compared to 
11.1% (n = 20) in those without intracranial complications. Several reports 
(Brook 2005c; Rosenfeld 1994, Mortimore et al 1998, Oxford, McClay 2005, 
Ali et el 2005) agree that anaerobes are commonly isolated from patents with 
intracranial complications. The third observation is that Streptococcus 
pneumoniae was not isolated from patients with intracranial complications.  
 
Johannesburg and Chris Hani Baragwanath Hospitals 
The Johannesburg Hospital and Chris Hani Baragwanath Hospitals are located 
to the north and south respectively, of the Johannesburg city centre and are 
separated by distance of about 30 kilometres. Most of the data collected in this 
study was derived from these two hospitals. The frequencies of the five most 
commonly isolated aerobic microorganisms (refer to page 23) occurring in 
patients at these two hospitals (Table 19) are found to be significantly different 
(p<0.05). This finding emphasizes the importance of having to know the local 
prevalence of microorganisms in ones area of practice (Lauer J 2003). 
 
The order of selected common microorganisms (refer to page 23) isolated at 
Johannesburg hospital occur in the order listed below: 
 β-haemolytic streptococci, 18 (20.5%) 
 coagulase negative staphylococcus, 13 (14.8%) 
 Staphylococcus aureus, 10 (11.4%) 
 Haemophilus influenzae, 7 (8.0%) 
 Streptococcus milleri, 2 (2.3%) 
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In contrast, the top order of the same selected common (refer to page 23) 
isolated microorganisms at the Chris Hani Baragwanath Hospital are: 
 Streptococcus milleri, 41 (28.3%) 
 Staphylococcus aureus, 19 (13.1%) 
 Haemophilus influenzae, 13 (9.0%) 
 β-haemolytic streptococci, 7 (4.8%) 
 coagulase negative staphylococcus, 4 (2.8%) 
  
The frequencies of isolation of Streptococcus milleri 41 (28.3%) and 
Haemophilus influenzae 13 (9.0%) were noted to be significantly higher 
(p<0.05) at the Chris Hani Baragwanath Hospital. The frequencies of isolation 
of β-haemolytic streptococci (group A, C, G and F) 18 (20.5%) and coagulase 
negative staphylococcus 13 (14.8%) are significantly higher (p<0.05) at the 
Johannesburg Hospital. The frequency of isolation of Streptococcus milleri 2 
(2.3%) at the Johannesburg Hospital is low (p<0.05). The frequencies of 
Staphylococcus aureus, Peptostreptococcus and Prevotella species at the two 
hospitals showed no significant difference (p>0.05). 
 
Ruoff (1988) pointed out that Streptococcus milleri has similar characteristics 
to the β-haemolytic streptococci (A, C, F and G) with which it is often 
mistaken to be. It is possible that this may partially explain the high frequency 
of β-haemolytic streptococci 18 (20.5%) coupled with the low frequency of 
Streptococcus milleri 2 (2.3%) seen at the Johannesburg Hospital (Table 19). 
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Children under the age of 16 years accounted for 40.6 % of the patients at the 
Johannesburg Hospital and 68.8% at the Chris Hani Baragwanath Hospital 
making the child to adult ratio 2:3 and 2:1 in the two hospitals respectively. 
The proportionally larger adult population of the Johannesburg Hospital would 
account for the higher occurrance of coagulase negative staphylococci. In a 
similar fashion, the higher proportion of children at Chris Hani Baragwanath 
Hospital would account for the significantly higher (p<0.05) occurrance of 
Haemophilus influenzae at this hospital. 
 
Antibiotic Susceptibility and Resistance 
Antibiotic susceptibility and resistance records were obtained for 129 patients. 
Susceptibility tests were not consistently reported for all common antibiotics 
and therefore significance levels of microorganism susceptibility and 
resistance to antibiotics were not tested in this study. With the results available 
certain trends were observed from which reasonable inferences could be made 
from specimen that contained single organisms. 
 
Streptococcus milleri was found to be highly susceptible to penicillin, 
ampicillin and erythromycin. Streptococcus milleri is recorded as being 
sensitive to penicillin in 84% of tested cases (Table 20) with the remaining 
16% being tested against cephalosporins. No penicillin resistance to 
Streptococcus milleri is reported in this study. Unfortunately this apparent 
benefit is offset by the fact that 18 of the 43 specimens that contained 
Streptococcus milleri were polymicrobial and contained penicillin resistant 
microorganisms in all cases (Table 21). 
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Penicillin, ampicillin and erythromycin were highly effective against β-
haemolytic streptococci, Streptococcus pneumoniae and streptococcal species. 
 
Cloxacillin was a highly effective agent against Staphylococcus aureus and 
coagulase negative staphylococci. Methicillin-resistant Staphylococcus was 
isolated in specimens from 2 children and 1 adult and was found to be 
susceptible to vancomycin. 
 
Haemophilus influenzae was resistant to ampicillin in 2 of 9 cases in which it 
was the sole pathogen. 
 
A simple count of the number of reported instances of antibiotic resistance 
was tabulated (Table 22). The penicillins, cotrimoxazole and the 
cephalosporins had the highest frequency. Snyman et al (1988) reported a 
similar trend and additionally pointed out that 100% of anaerobes were 
susceptible to metronidazole. In this study some anaerobes were found to be 
susceptible to clindamycin and no susceptibility testing to metronidazole was 
recorded. 
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CONCLUSION 
 
Streptococcus milleri, Staphylococcus aureus, β-haemolytic streptococci, 
coagulase negative staphylococci, Haemophilus influenzae and the anaerobes, 
Peptostreptococci and Prevotella species, are important causative pathogens 
found in patients presenting with acute complicated bacterial sinusitis to the 
Witwatersrand ENT complex. 
 
The frequent isolation of Staphylococcus aureus, coagulase negative 
staphylococci and anaerobes suggests acute exacerbation of chronic sinusitis 
to be a common presenting form of the disease. 
 
Haemophilus influenzae appears to be a more important pathogen in children 
than in adults. 
 
Streptococcus pneumoniae and Moraxella catarrhalis are not major pathogens 
in patients with acute complicated sinusitis at the University of the 
Witwatersrand ENT complex. 
 
Initial antibiotic therapy, prior to obtaining culture and sensitivity results, 
should include antibiotics that cover: 
 Streptococcus milleri, β-haemolytic streptococci, Staphylococcus aureus, 
coagulase negative staphylococci and anaerobes in children and adults 
 Haemophilus influenzae especially in children
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APPENDIX: I 
Key: 
C: Coronation Hospital 
J:  Johannesburg General Hospital 
B: Chris Hani Baragwanath Hospital 
HJ: Helen Joseph Hospital  
NPRF: No postoperative results found 
 
UNFILTERED RAW DATA
Hospital Month Year Gender Age Hospital Reference Neurosurgery Aerobic Organisms Anaerobic Organisms 
B 1 2002 F 10 GT08914876 No HISTOLOGY  
J 10 2002 M 17 GT00003915 Yes coagulase negative 
staphylococcus, Streptococcus 
group C 
 
J 11 2002 F 44 GP00009426 No NO BACTERIAL GROWTH  
B 1 2002 M 15 GT08657938 No NO BACTERIAL GROWTH  
B 6 2002 M 17 GT08822814 No HISTOLOGY  
B 6 2002 M 21 GT08856416 No HISTOLOGY  
B 7 2002 F 10 GT08860806 No HISTOLOGY  
HJ 10 2002 M 20 030882 No NPRF  
B 8 2002 M 17 GT08858541 No HISTOLOGY  
B 8 2002 M 12 GT08875047 No HISTOLOGY  
B 1 2002 M 8 GT08910260 No HISTOLOGY  
J 11 2002 F 8 GT00020680 No NO BACTERIAL GROWTH  
J 10 2002 M 0 GT00049171 No NPRF  
J 4 2002 F 21 2775626 No Staphylococcus aureus  
B 9 2002 F 19 GT08867395 No HISTOLOGY  
J 1 2002 M 0 2751127 No NPRF  
J 3 2002 M 18 2761871 No Klebsiella oxytoca, 
Streptococcus viridans 
 
B 8 2002 F 15 GT08627226 No HISTOLOGY  
J 3 2002 F 37 2767157 No NPRF  
J 10 2002 M 37 GT00012416 No Streptococcus group G, 
Staphylococcus aureus, 
Corybacterium species 
 
J 6 2002 M 28 2784384 Yes NPRF  
J 7 2002 M 16 2793646 No Streptococcus group F  
J 7 2002 F 47 2751363 No NO BACTERIAL GROWTH  
J 10 2002 M 17 GT00003915 No Coagulase negative 
staphylococcus, Streptococcus 
group C 
 
J 10 2002 F 0 GT00 No NPRF  
J 3 2002 M 28 2763946 No NPRF  
J 2 2003 M 29 GT00077876 No NO BACTERIAL GROWTH  
J 3 2003 F 18 GT00089475 No coagulase negative 
staphylococcus 
 
J 3 2003 M 37 GT00029674 No NO BACTERIAL GROWTH  
J 9 2003 M 71 GP00018553 No NPRF  
J 9 2003 F 14 GT00148482 No NO BACTERIAL GROWTH  
J 3 2003 F 12 GT00025216 No Streptococcus pyogenes  
J 8 2003 M 14 GT00106321 No Streptococcus species  
B 3 2003 F 15 GT08961344 Yes HISTOLOGY  
J 3 2003 F 18 GT00089475 No coagulase negative 
staphylococcus 
 
J 4 2003 F 45 GP00009426 No NO BACTERIAL GROWTH  
J 4 2003 M 15 GT00097286 No Streptococcus pyogenes  
J 7 2003 M 24 GT00123929 No NPRF  
J 7 2003 F 17 GT08990866 No Coagulase negative 
staphylococcus, Streptococcus 
viridans 
Prevotella species 
J 7 2003 F 15 GT00054156 No Streptococcus species  
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UNFILTERED RAW DATA
Hospital Month Year Gender Age Hospital Reference Neurosurgery Aerobic Organisms Anaerobic Organisms 
J 7 2003 M 12 GT00125602 No NPRF  
J 10 2003 M 39 GT00012575 No coagulase negative 
staphylococcus 
 
J 7 2003 M 15 GT00125340 No NO BACTERIAL GROWTH  
J 7 2003 M 17 GT08990866 Yes NPRF  
B 1 2003 M 33 GP08658493 No HISTOLOGY  
J 7 2003 M 16 GT00125240 No Haemophilus influenzae, 
coagulase negative 
staphylococcus 
 
J 7 2003 M 13 GT00129313 No SPECIMEN REJECTED  
J 8 2003 M 14 GT00106321 No Streptococcus species  
J 9 2003 M 14 GT00141667 Yes Streptococcus species  
J 7 2003 M 15 GT00125340 No NO BACTERIAL GROWTH  
HJ 3 2003 M 15 271188 No NPRF  
B 5 2003 M 62 GT08983219 No HISTOLOGY  
HJ 1 2003 M 16 010886 No NPRF  
HJ 9 2003 M 20 241283 No NPRF  
J 7 2003 M 8 GT00113240 No Streptococcus species  
B 1 2003 F 3 GT08928276 No Streptococcus pyogenes  
B 12 2003 F 10 GT09053907 No HISTOLOGY  
B 7 2003 M 3 GT09001956 No HISTOLOGY  
B 9 2003 F 13 GT09026403 No HISTOLOGY  
B 9 2003 F 8 GT09020126 No HISTOLOGY  
B 8 2003 M 17 GT09016846 No HISTOLOGY  
B 8 2003 F 13 GT08780380 No Streptococcus group C Peptostreptococcus species 
B 10 2003 M 26 GP08687086 No HISTOLOGY  
B 3 2004 F 24 GT08996351 No HISTOLOGY  
J 12 2004 M 10 GT00268996 No Haemophillus influenzae, 
Stapylococcus aureus, beta 
lactamase negative 
 
J 11 2004 M 11 GT00259464 Yes Streptococcus Group F  
J 9 2004 M 10 GT00244914 No  Peptostreptococcus species, 
Propionbacterium species 
J 8 2004 F 14 GT00234630 No NPRF  
J 8 2004 M 11 GT00231140 No NPRF  
J 7 2004 M 9 GT00228635 No Streptococcus Group F  
J 9 2004 M 19 GT00243578 No Streptococcus Group C  
J 7 2004 F 43 GT00128608 No Streptococcus pyogenes  
B 5 2004 F 8 GT09107687 No HISTOLOGY  
B 10 2004 M 16 GT09172159 No HISTOLOGY  
J 8 2004 M 17 GT00235918 No NO BACTERIAL GROWTH  
J 8 2004 M 19 GT00243578 No Streptococcus Group C  
B 9 2004 F 52 GP54157505 No HISTOLOGY  
B 9 2004 M 13 GT09144632 No Haemophilus influenzae  
J 8 2004 M 17 GT00235918 No NO BACTERIAL GROWTH  
J 7 2004 M 24 GT00161104 No coagulase negative 
staphylococcus 
Peptostreptococcus 
anaerobius 
J 5 2004 M 9 GT00216036 No Hameophillus influenzae, 
Streptococcus species 
 
J 7 2004 M 20 GT00226693 No Staphylococcus species  
J 5 2004 F 3 GT00206092 No Bacteroides species  
J 7 2004 M 17 GT00235198 No NPRF  
B 11 2004 F 16 GT09175830 No HISTOLOGY  
B 11 2004 M 8 GT08910260 No HISTOLOGY  
B 7 2004 M 7 GT09134118 No HISTOLOGY  
J 6 2004 M 12 GT00219151 Yes Haemophillus influenzae  
J 6 2004 F 0 GT00 No NPRF  
HJ 9 2004 M 30 120174 No NPRF  
J 5 2004 M 14 GT00214135 No NO BACTERIAL GROWTH  
J 9 2004 F 13 GT00238098 No NO BACTERIAL GROWTH  
J 7 2004 F 3 GT00224779 No NPRF  
B 2 2004 M 6 GT08725154 No HISTOLOGY  
J 11 2004 F 9 GT00208012 No Streptococcus group F  
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B 2 2004 F 23 GT09038493 No HISTOLOGY  
B 12 2004 M 12 GT09192082 Yes HISTOLOGY  
B 9 2005 M 12 GT09293475 No Corynebacterium species  
J 8 2005 F 12 GT00337247 No NO BACTERIAL GROWTH  
J 8 2005 F 10 GT00334021 No NO BACTERIAL GROWTH  
J 7 2005 M 14 GT00326841 No Streptococcus viridans  
J 7 2005 M 10 GT00301802 No NO BACTERIAL GROWTH  
J 7 2005 M 15 GT00318117 No coagulase negative staphylococci  
J 4 2005 M 8 GT00300502 No NO BACTERIAL GROWTH  
J 4 2005 F 9 GT00300360 No Haemophillus influenzae  
B 8 2005 M 12 GT09286809 Yes Streptococcus milleri, 
Streptococcus viridans, 
Haemophillus influenzae 
Photobacter species 
J 9 2005 F 9 GT00337188 No Streptococcus Group F  
B 8 2005 M 15 GT09287250 No Streptococcus milleri  
J 10 2005 M 12 GT00138399 No NO BACTERIAL GROWTH  
B 9 2005 M 15 GT09292518 No NO BACTERIAL GROWTH  
B 9 2005 M 18 GT09295919 No Klebsiella species, Streptococcus 
milleri 
 
B 10 2005 M 14 GT09307936 No Staphylococcus aureus  
B 10 2005 M 13 GT09136246 Yes Streptococcus viridans  
B 11 2005 M 9 GT09308983 No Streptococcus milleri  
B 8 2005 F 29 GP54203998 No NO BACTERIAL GROWTH  
B 8 2005 M 14 GT09281958 Yes NO BACTERIAL GROWTH  
B 7 2005 M 15 GT09263662 Yes HISTOLOGY  
B 7 2005 M 14 GT09266162 No NO BACTERIAL GROWTH  
B 7 2005 F 13 GT09271118 Yes Eikenella corrodens  
B 7 2005 M 12 GT09272486 Yes Streptococcus milleri  
B 8 2005 M 6 GT08683711 No NO BACTERIAL GROWTH  
B 8 2005 F 12 GT09280111 No NO BACTERIAL GROWTH  
B 8 2005 M 15 GT09280044 No Streptococcus milleri  
J 9 2005 M 13 GT00340696 No Staphylococcus aureus  
B 7 2005 M 13 GT09273903 Yes Streptococcus milleri  
B 11 2005 M 7 GT09316900 No Streptococcus milleri  
B 8 2005 M 16 GT09285409 No  Prevotella species 
J 7 2005 M 18 GT00325227 Yes Streptococcus pyogenes  
J 7 2005 M 16 GT00324065 Yes Streptococcus group C  
J 7 2005 M 17 GT00328963 Yes NO BACTERIAL GROWTH  
J 12 2005 F 7 GT00362462 No NO BACTERIAL GROWTH  
J 10 2005 F 9 GT00352367 No NO BACTERIAL GROWTH  
B 12 2005 F 30 GT09233906 No Escherichia coli, Staphylococcus 
aureus, Enterobacter faecalis 
 
J 9 2005 F 9 GT00342541 No Streptococcus species  
B 7 2005 M 14 GT09273764 Yes Streptococcus milleri Peptostreptococcus species 
J 6 2005 F 22 GT00315641 No Streptococcus milleri  
B 11 2005 M 7 GP08776376 No Staphylococcus aureus  
J 12 2005 F 31 GT00295842 No NPRF  
J 11 2005 F 42 GP08659576 No NPRF  
J 10 2005 M 9 GT00347272 No Streptococcus species Fusobacterium species 
J 9 2005 M 23 GT00345279 No NO BACTERIAL GROWTH  
J 8 2005 M 19 GT08990866 No Streptococcus species  
J 7 2005 F 48 GT00328283 No NPRF  
J 2 2005 M 8 GT00284835 No NPRF  
J 10 2005 M 39 GT00345236 No Staphylococcus aureus  
J 2 2005 M 13 GT00279643 No NO BACTERIAL GROWTH  
J 5 2005 F 22 GT00312150 No Staphylococcus aureus  
J 5 2005 M 32 GT00301382 No  Peptostreptococcus 
anaerobius 
J 4 2005 M 48 GT00294653 No Candida glabrata Sacchromyces cerevisiae 
J 4 2005 M 18 GT00296803 No NO BACTERIAL GROWTH  
J 4 2005 M 16 GT00294075 No NO BACTERIAL GROWTH  
J 2 2005 M 16 GT00280429 No  Peptostreptococcus 
anaerobius 
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J 1 2005 M 32 GT00277450 No Staphylococcus species  
J 1 2005 M 30 GT00273338 No Corynebacterium species  
J 4 2005 F 0 GT00707 No INCOMPLETE 
INFORMATION 
 
B 12 2005 F 13 GT09323240 No Streptococcus milleri, 
Staphylococcus aureus 
 
B 12 2005 F 21 GT09320305 No MRSA  
J 3 2005 M 9 GT00290281 No Staphylococcus aureus Peptostreptococcus 
anaerobius 
J 3 2005 F  GT00286552 No NPRF  
J 2 2005 M 13 GT00282005 No Staphylococcus aureus  
J 2 2005 M 9 GT00280113 No NO BACTERIAL GROWTH  
J 1 2005 M 12 GT00275098 No NO BACTERIAL GROWTH  
J 1 2005 M 13 GT00274341 No NO BACTERIAL GROWTH  
B 6 2005 F 11 GT09257914 No Streptococcus milleri Acinetobacter baumanii 
B 12 2005 M 10 GT09323020 Yes Streptococcus milleri Peptostreptococcus species 
J 12 2005 F 37 GT00363992 No NPRF  
B 12 2005 M 13 GT09328157 No NO BACTERIAL GROWTH  
B 12 2005 F 8 GT09328296 No Staphylococcus aureus, 
Streptococcus pneumoniae 
 
B 7 2005 M 16 GT09273228 No Streptococcus milleri  
J 4 2005 M 39 GT00293563 No Streptococcus viridans  
J 2 2005 F 37 GT00240840 No NPRF  
J 2 2005 M 28 GT00280611 No NPRF  
J 1 2005 M 34 GT00276209 No NPRF  
J 1 2005 M 12 GT00275175 No NPRF  
J 1 2005 M 8 GT00272180 No NO BACTERIAL GROWTH  
B 8 2005 M 14 GT09277028 No Haemophillus species, 
Streptococcus pneumonie 
 
B 6 2005 M 17 GT09260003 Yes Streptococcus milleri, 
Streptococcus viridans 
Prevotella species 
B 6 2005 M 10 GT09262108 Yes Streptococcus milleri  
J 2 2005 M 17 GT00153011 No Staphylococcus aureus  
B 6 2005 M 12 GT09260397 Yes Coagulase negative 
staphylococcus 
Peptostreptococcus species 
B 1 2005 F 13 GT54284363 Yes NPRF  
B 6 2005 M 10 GT09262108 Yes Streptococcus milleri  
B 8 2005 M 13 GT09255063 Yes  Peptostreptococcus 
species,Prevotella species 
HJ 3 2005 M 28 010186 No NPRF  
HJ 6 2005 M 18  No NPRF  
J 12 2005 M 11 GT00360829 No Haemophillus parainfluenzae  
J 5 2005 M 17 GT00399640 No Streptococcus group C  
B 2 2005 M 8 GT09214991 No Staphylococcus aureus  
B 2 2005 M 10 GT09180627 No Streptococcus pneumoniae  
B 4 2005 M 15 GT09237430 No NO BACTERIAL GROWTH  
B 6 2005 F 10 GT09259309 No Streptococcus milleri  
B 3 2005 F 8 GT09222799 No Haemophilus influenzae, 
Streptococcus milleri 
 
B 6 2005 F 31 GP08753659 No Staphylococcus aureus  
B 2 2005 F 46 GT09209286 No Klebsiella ozaenae  
B 6 2005 M 15 GT09251701 No NO BACTERIAL GROWTH  
B 5 2005 M 14 GT09251635 No Streptococcus pneumoniae, 
Haemophilus influenzae 
 
B 6 2005 M 4 GT09257919 No Streptococcus pneumonie  
B 3 2005 M 4 GT09219375 No Haemophillus influenzae, 
Moraxella catarrhalis 
 
HJ 8 2005 M 15 121190 No NPRF  
B 8 2005 F 24 GT08732936 No Pseudomonas aeruginosa, 
Staphylococcus aureus 
 
B 5 2005 M 24 GT09250952 No Haemophilus influenzae, Proteus 
mirabilis 
 
B 5 2005 M 24 GP08751432 No Streptococcus milleri, coagulase 
negative staphylococci 
Peptostreptococcus species 
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B 5 2005 F 5 GT09240510 No Haemophilus influenzae  
B 9 2006 M 7 GT54246749 No Streptococcus viridans Peptostreptococcus species 
B 7 2006 M 7 GT09418294 No Streptococcus milleri  
B 9 2006 F 8 GT09443628 No Streptococcus group F  
B 11 2006 M 8 GT25378030 Yes Streptococcus group C, 
Staphylococcus aureus 
Prevotella species 
B 9 2006 F 13 GT09440553 No Streptococcus milleri 
(anginosus) 
 
B 8 2006 M 13 GT09436737 No Streptococcus milleri 
(anginosus) 
Prevotella species 
B 8 2006 M 17 GT09437713 No Streptococcus milleri  
B 8 2006 M 8 GT09436213 No Streptococcus milleri  
B 9 2006 M 10 GT09442662 No NO BACTERIAL GROWTH  
J 5 2006 F 3 GT00395518 No NPRF  
B 8 2006 F 19 GT09433392 Yes NO BACTERIAL GROWTH  
B 8 2006 M 16 GT09432955 No coagulase negative 
staphylococcus, Streptococcus 
viridans 
 
B 8 2006 M 21 GP25412996 No NO BACTERIAL GROWTH  
B 7 2006 M 12 GT09420090 No NO BACTERIAL GROWTH  
B 7 2006 M 12 GT09423660 No Streptococcus milleri  
B 6 2006 M 12 GT54346960 Yes Streptococcus milleri, Eikenella 
corrodens 
 
B 10 2006 F 11 GT09465082 No NPRF  
B 7 2006 F 10 GT09421852 No Staphylococcus aureus  
B 7 2006 M 9 GT09421257 No Streptococcus pneumoniae  
B 7 2006 M 18 GT09428490 No Streptococcus milleri  
B 1 2006 M 14 GT09331056 Yes Streptococcus species, 
Haemophillus influenzae 
Prevotella species 
B 6 2006 M 14 GT9410530 No Enterobacter cloacae  
B 12 2006 M 10 GT09477335 No Streptococcus group C Peptostreptococcus species 
B 11 2006 M 27 GT09467884 No NO BACTERIAL GROWTH  
B 11 2006 F 44 GP08642734 No NPRF  
B 11 2006 M 19 GT09469691 Yes Citrobacter koserii, Klebsiella 
oxytoca, Staphylococcus aureus 
 
B 11 2006 M 9 GT09463490 No Haemophillus influenzae  
B 11 2006 M 6 GT09463881 No Staphylococcus aureus, 
Streptococcus viridans, Eikenella 
corrodens 
 
J 6 2006 F 19 GT00407066 No Corynebacterium species  
B 10 2006 M 25 GT09450744 No Streptococcus milleri  
B 7 2006 M 17 GT09420841 No Streptococcus milleri, 
Escherichia coli 
 
B 6 2006 F 11 GT00263410 Yes Streptococcus milleri Prevotella species, 
Peptostreptococcus species 
B 1 2006 F 54 GT09327387 No Haemophillus influenzae  
B 1 2006 F 26 GT09333130 No Streptococcus pyogenes  
B 1 2006 F 16 GT09335254 No Streptococcus milleri  
B 1 2006 F 15 GT09336425 No NO BACTERIAL GROWTH  
B 2 2006 F 23 GT09344703 No Staphylococcus aureus  
B 6 2006 M 15 GT25680372 Yes Streptococcus milleri, coagulase 
negative staphylococcus 
 
B 8 2006 F 20 GP08811240 Yes Streptococcus milleri, coagulase 
negative staphylococcus, 
Klebsiella species 
 
B 8 2006 M 11 GT09436667 Yes Streptococcus group C Prevotella species 
B 11 2006 M 8 GT25378030 Yes NPRF  
B 10 2006 M 13 GT09453243 No NPRF  
J 1 2006 F 1 GT00370305 No NO BACTERIAL GROWTH  
B 4 2006 M 16 GT0932287 Yes NO BACTERIAL GROWTH  
B 4 2006 M 43 GP08660768 No NO BACTERIAL GROWTH  
B 4 2006 F 39 GP08792920 No NO BACTERIAL GROWTH  
B 3 2006 F 74 GT00032207 No Streptococcus milleri  
B 3 2006 M 14 GT09378327 Yes Streptococcus milleri, MRSA  
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B 2 2006 M 16 GT09364209 No NO BACTERIAL GROWTH  
B 2 2006 M 30 GP08786445 No Streptococcus milleri  
B 2 2006 M 10 GT09345756 Yes Haemophillus influenzae, 
Staphylococcus aureus 
 
J 9 2006 M 16 GT00427174 No coagulase negative staphylococci  
J 11 2006 M 5 GT00441951 No Staphylococcus aureus  
B 3 2006 M 14 GT09378327 Yes MRSA  
J 5 2006 M 17 GT00399640 No Streptococcus Group C  
J 6 2006 M 30 GT00407562 No Streptococcus species, Klebsiella 
species 
 
B 4 2006 M 15 GT09395638 Yes NO BACTERIAL GROWTH  
J 3 2006 F 3 GT00340474 No coagulase negative staphylococci  
J 3 2006 M 13 GT00381531 No NO BACTERIAL GROWTH  
J 6 2006 M 17 GT00403292 No NO BACTERIAL GROWTH  
J 6 2006 M 10 GT00403025 Yes Streptococcus milleri  
J 6 2006 M 18 GT00406043 No coagulase negative 
staphylococci, Streptococcus 
group C 
 
J 7 2006 M 18 GT00411633 No coagulase negative 
staphylococcus 
 
HJ 9 2006 M 41 150666 No NPRF  
HJ 5 2006 F 30 250275 No NPRF  
HJ 3 2006 F 15 230491 No NPRF  
C 2 2006 M 13 030692 No coagulase negative 
staphylococcus 
 
C 10 2006 F 6 310500 No NO BACTERIAL GROWTH  
J 8 2006 M 4 GT00422022 No NO BACTERIAL GROWTH  
B 6 2006 M 20 GT09410519 No Streptococcus milleri  
B 7 2006 M 21 GP25412996 No NO BACTERIAL GROWTH  
B 7 2006 M 17 GP08805735 No Klebsiella species  
J 1 2006 M 18 GT00369293 No Straphylococcus species, 
Enterococcus durans 
 
J 2 2006 F 46 GT00373558 No Yeast-like organisms  
J 3 2006 F 20 GT00386563 No Haemophilus influenzae  
J 6 2006 M 17 GT00403292 No Streptococcus species, 
Lactobacillus species 
 
J 6 2006 M 30 GT00407562 No Haemophillus influenzae  
B 6 2006 M 8 GT08750760 No Staphylococcus aureus  
B 6 2006 M 7 GT09412724 No NO BACTERIAL GROWTH  
B 6 2006 F 19 GT09411501 No Staphylococcus aureus  
B 4 2006 F 15 GT08907215 No Haemophillus influenzae  
B 6 2006 M 14 GT09410530 No Enterobacteracea cloacae  
B 4 2006 F 23 GT09395317 No NO BACTERIAL GROWTH  
B 6 2006 F 10 GT09607133 Yes NO BACTERIAL GROWTH  
B 6 2006 M 15 GT09408339 Yes Streptococcus milleri  
J 1 2006 M 68 GT00367659 No NPRF  
J 1 2006 F   No INCOMPETE INFORMATION  
B 6 2006 F 28 GT09407869 No  Prevotella species, 
Peptostreptococcus species 
B 5 2006 M 12 GT09407142 No Staphylococcus aureus  
B 5 2006 M 15 GT09405292 No Streptococcus milleri, Eikenella 
corrodens 
 
B 5 2006 M 12 GT25566364 No Haemophillus influenzae, 
Staphylococcus aureus 
Prevotella species 
B 5 2006 M 16 GT09401597 No Streptococcus milleri  
B 5 2006 F 10 GT09399932 No Staphylococcus aureus, 
Streptococcus milleri 
 
B 5 2006 F 3 GT09397543 No NO BACTERIAL GROWTH  
B 7 2006 M 12 GT09420090 No NO BACTERIAL GROWTH  
B 6 2006 M 14 GT08706651 No Haemophillus parainfluenza, 
coagulase negative staphylococci
Prevotella species 
B 8 2008 M 10 GT09431814 No NO BACTERIAL GROWTH  
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J 7 2002 2793646 Penicillin, Ampicillin, Erythromycin  No 1 
J 10 2002 GT00003915 Co-amoxiclav, Rifampicin, 
Vancomycin, Fucidic acid 
Penicillin, Ampicillin, 
Erythromycin, Cloxacillin 
Yes 2 
J 10 2002 GT00003915 Cotrimoxazole, Rifampicin, 
Vancomycin, Fucidic acid 
Penicillin, Ampicillin, 
Erythromycin, Cloxacillin 
Yes 2 
J 4 2002 2775626 Cloxacillin, erythromycin, 
clindamycin, cotrimoxazole 
Penicillin, Ampicillin Yes 1 
J 3 2002 2761871 Co-amoxiclav, cefzolin, cephalexin, 
gentamicin, cotrimxazole 
Penicillin, Ampicillin Yes 2 
J 10 2002 GT00012416  Penicillin, Ampicillin Yes 3 
J 4 2003 GT00097286 Penicillin, Ampicillin, Erythromycin  No 1 
J 8 2003 GT00106321 Penicillin, Ampicillin, Erythromycin, 
Tetracycline 
 No 1 
J 7 2003 GT00125240 Ampicillin  No 2 
J 7 2003 GT00113240 Penicillin, Ampicillin, Erythromycin Tetracycline No 1 
J 7 2003 GT00054156   No 1 
J 7 2003 GT08990866 Ceftriaxone, Cefotaxime, 
Erythromycin, Vancomycin 
Penicillin, Ampicillin, 
Tetracycline 
Yes 3 
J 3 2003 GT00025216 Penicillin, Ampicillin, Erythromycin, 
Vancomycin 
 No 1 
J 8 2003 GT00106321 Penicillin, Ampicillin, Erythromycin, 
Tetracycline 
 No 1 
J 11 2004 GT00208012 Penicillin, Ampicillin, Erythromycin  No 1 
J 7 2004 GT00228635 Penicillin, Ampicillin, Erythromycin  No 1 
J 9 2004 GT00243578 Peniclillin, Ampicillin, Cefuroxime, 
Cefotaxime 
 No 1 
J 7 2004 GT00128608 Penicillin, Ampicillin, Erythromycin  No 1 
J 8 2004 GT00243578 Penicillin, Ampicillin, Ceftriaxone, 
Cefotaxime 
 No 1 
J 6 2004 GT00219151 Ampicillin  No 1 
J 9 2004 GT00244914 Penicillin, Ampicillin, Erythromycin  No 2 
J 5 2004 GT00216036 Ampicillin  No 2 
J 7 2004 GT00161104 Cloxacillin, Erythromycin, 
Cefotaxime, Rifampicin, 
Vancomycin, Fucidicacid 
Penicillin, Ampicillin Yes 2 
B 9 2004 GT09144632 Ampicillin, Cotrimoxazole, 
Cefuroxime, Tetracycline 
 No 1 
B 5 2005 GT09240510 Co-amoxiclav, Cefotaxime, 
Ceftriaxone 
 No 1 
J 6 2005 GT00315641 Penicillin, Ampicillin, Erythromycin, 
Clindamycin 
 Yes 1 
J 10 2005 GT00345236 Cloxacillin, Erythromycin, 
Clindamycin, Cotrimoxazole 
Peniclillin, Ampicillin Yes 1 
J 3 2005 GT00290281 Cloxacillin, Erythromycin, 
Clindamycin, Cotrimoxazole 
Penicillin, Ampicillin Yes 2 
B 6 2005 GT09262108 Penicillin, Ampicillin, Erythromycin  No 1 
B 2 2005 
 
 
GT09180627 Penicillin, Ampicillin, Erythromycin, 
Cotrimoxazole, Chloramphenicol, 
Clindamycin, Tetracycline 
 No 1 
J 7 2005 GT00326841 Vancomycin, Linezolid Penicillin, Ampicillin, 
Erythromycin, Clindamycin 
Yes 1 
B 7 2005 GT09273764 Penicillin  No 2 
B 7 2005 GT09272486 Penicillin  No 1 
J 4 2005 GT00293563 Cefotaxime, Ceftriaxone  No 1 
B 7 2005 GT09273903 Penicillin  No 1 
B 3 2005 GT09222799 Penicillin, Ampicillin, Erythromycin, 
Cefuroxime 
 No 2 
B 7 2005 GT09273228 Penicillin  No 1 
B 6 2005 GT09260003 Penicillin  No 3 
B 5 2005 GP08751432 Penicillin, Ampicillin, Erythromycin, 
Clindamycin, Cefotaxime, 
Ceftriaxone 
 No 3 
 - 68 -
ANTIBIOTIC SUSCEPTIBILITY AND RESISTANCE RECORDS
Hospital Month Year Hospital Reference Susceptibility Resistance 
Penicillin 
Resistance 
Number 
of 
isolates 
B 8 2005 GT09277028 Penicillin, Ampicillin  No 2 
B 5 2005 GT09250952 Ampicillin, Cotrimoxazole  No 2 
B 8 2005 GT08732936 Cloxacillin, Cotrimxazole, 
Ceftazidime, Amikacin, Cefepime 
 Yes 2 
B 3 2005 GT09219375 Ampicillin, Cotrimoxazole  No 2 
B 5 2005 GT09251635 Penicillin, Ampicillin, Erythromycin, 
Cotrimoxazole, Co-amoxiclav 
 No 2 
J 12 2005 GT00360829 Ampicillin, Tetracycline, Cefuroxime Cotrimoxazole No 1 
J 5 2005 GT00399640 Penicillin, Ampicillin, Erythromycin  No 1 
J 2 2005 GT00282005 Cloxacillin, Cotrimoxazole Penicillin, Ampicillin, 
Erythromycin 
Yes 1 
B 2 2005 GT09209286 Ampicillin, Co-amoxiclav, 
Olfoxacin, Ciprofloxacin, 
Gentamicin, Amikacin, Cefzolin, 
Cephalexin 
 No 1 
B 6 2005 GT09262108 Penicillin, Ampicillin, Erythromycin  No 1 
B 12 2005 GT09323240 Penicillin, Cloxacillin  No 2 
B 2 2005 GT09214991 Cloxacillin, Clindamycin, 
Cotrimoxazole, Erythromycin 
 No 1 
B 8 2005 GT09280044 Penicillin  No 1 
B 8 2005 GT09286809 Penicillin, Ampicillin  No 4 
B 8 2005 GT09287250 Penicillin  No 1 
B 9 2005 GT09295919 Co-amoxiclav, Cefuroxime, 
Gentamicin, Penicillin 
Ampicillin, Amoxycillin Yes 2 
B 10 2005 GT09307936 Cloxacillin, Erythromycin, 
Clindamycin 
Penicillin, Ampicillin Yes 1 
B 11 2005 GT09308983 Penicillin, Ampicillin, Erythromycin, 
Cefotaxime, Ceftriaxone 
 No 1 
B 11 2005 GT09316900 Penicillin  No 1 
B 11 2005 GP08776376 Cloxacillin, Erythromycin, 
Clindamycin 
Penicillin, Ampicillin Yes 1 
B 12 2005 GT09320305 Vancomycin Cloxacillin, Penicillin, 
Ampicillin, Ertythromycin, 
Clindamycin, Cotrimoxazole, 
Rifampicin, Gentamicin 
Yes 1 
J 5 2005 GT00312150 Cloxacillin, Erythromycin, 
Clindamycin, Cotrimoxazole 
Peniclillin, Ampicillin Yes 1 
B 12 2005 GT09323020 Penicillin  No 2 
B 12 2005 GT09328296 Penicillin, Cloxacillin  No 2 
J 9 2005 GT00337188 Penicillin, Ampicillin Tetracycline No 1 
J 9 2005 GT00340696 Cloxacillin, Erythromycin, 
Clindamycin, Cotrimoxazole 
Penicillin, Ampicillin Yes 1 
J 4 2005 GT00300360 Cefuroxime Ampicillin, Cotrimoxazole, 
Chloramphenicol 
Yes 1 
J 7 2005 GT00324065 Penicillin, Ampicillin  No 1 
J 7 2005 GT00325227 Penicillin, Ampicillin, Erythromycin  No 1 
B 6 2005 GT09257914 Penicillin, Imipenem, Meropenem  No 2 
B 6 2005 GT09259309 Penicillin, Ampicillin, Erythromycin  No 1 
B 6 2005 GT09257919 Penicillin  No 1 
B 6 2005 GP08753659 Cloxacillin Penicillin, Ampicillin Yes 1 
J 2 2005 GT00153011 Cloxacillin, Erythromycin, 
Cotrimoxazole 
Penicillin, Ampicillin, 
Ofloxacin, Ci[rofloxacin 
Yes 1 
B 12 2005 GT09233906 Piperacillin, Ceftraxone, Gentamicin, 
Penicillin, Cloxacillin 
 No 3 
J 3 2006 GT00386563 Ampicillin Cotrimoxazole No 1 
J 5 2006 GT00399640 Penicillin, Ampicillin, Erythromycin  No 1 
J 1 2006 GT00369293 Linezolid, Vancomycin Cloxacillin, Ampicillin, 
Erythromycin, Clindamycin, 
Cotrimoxazole 
Yes 2 
B 6 2006 GT54346960 Penicillin, Ampicillin, Erythromycin  No 2 
B 6 2006 GT00263410 Penicillin  No 3 
B 8 2006 GT09436667 Penicillin, Ampicillin, Erythromycin  No 1 
B 8 2006 GP08811240 Penicillin, Ceftriaxone, Cefotaxime, 
Ertapenem, Meropenem, Gentamicin, 
Ampicillin, Amoxiil, 
Cefazol, Cephalex, 
Yes 3 
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Imipenem Piperacillin-Tazobactam, 
Cefotaxime, Ceftriaxone, 
Ceftazidime, Coamoxiclav, 
Cotrimoxazole, Amikacin, 
Tobramycin 
B 6 2006 GT25680372 Penicillin, Ampicillin, Erythromycin  No 2 
B 2 2006 GT09344703 Cloxacillin  Yes 1 
B 1 2006 GT09335254 Penicillin  No 1 
B 1 2006 GT09333130 Penicillin  No 1 
B 1 2006 GT09327387 Ampicillin  No 1 
B 1 2006 GT09331056 Penicillin, Ampicillin  No 3 
J 6 2006 GT00407562 Ampicillin, Cefuroxime Cotrimoxazole No 1 
B 8 2006 GT09436737 Cefotaxime, Ceftiaxone  No 2 
B 7 2006 GT09420841 Penicillin, Ampicillin, Clindamycin; 
Cefotaxime, Ceftriaxone 
 No 2 
B 7 2006 GT09421257  Penicillin Yes 1 
B 7 2006 GT09421852 Cloxacillin, Erythromycin, 
Clindamycin, Cotrimoxazole 
Penicillin, Ampicillin Yes 1 
B 7 2006 GT09423660 Penicillin, Ampicillin, Cefotaxime, 
Ceftriaxone 
 No 1 
B 7 2006 GT09428490 Penicillin, Ampicillin, Cefotaxime, 
Ceftriaxone 
 No 1 
B 8 2006 GT09432955 Cefotaxime, Ceftiaxone  No 2 
B 7 2006 GT09418294 Cefotaxime, Ceftiaxone  No 1 
C 2 2006 030692 Cloxacillin, Erythromycin, 
Clindamycin, Cotrimoxazole, 
Gentamicin 
Penicillin, Ampicillin Yes 1 
B 8 2006 GT09437713 Cefotaxime, Ceftiaxone  Yes 1 
B 6 2006 GT09411501 Cloxacillin, Cotrimoxazole Penicillin, Ampicillin Yes 1 
B 9 2006 GT09440553 Penicillin, Ampicillin, Erythromycin  No 1 
B 9 2006 GT54246749 Cefotaxime, Ceftiaxone  No 2 
B 9 2006 GT09443628 Penicillin, Ampicillin, Cefotaxime, 
Ceftiaxone 
 No 1 
B 10 2006 GT09450744 Penicillin, Ampicillin  No 1 
B 11 2006 GT09463490 Ampicillin, Cotrimoxazole, 
Cefuroxime 
 No 1 
B 11 2006 GT09469691 Cotrimoxazole, Cloxacillin, 
Erythromycin, Clindamycin, 
Cefotaxime, Ceftriaxone, 
Ciprofloxacin, Co-amoxiclav, 
Gentamicin 
Amoxycillin, Penicillin, 
Ampicillin 
Yes 3 
B 12 2006 GT09477335 Penicillin, Ampicillin, Erythromycin  No 2 
B 6 2006 GT9410530 Ciprofloxacin, Cefepime, Amikacin, 
Ertapenem, Gentamicin 
Ampicillin, Amoxycillin, 
Cefazolin, Cefuroxime, 
Cephalexin, Ceftraxone, 
Cefotaxime, Piperacillin-
Tazobactam 
Yes 1 
B 8 2006 GT09436213 Cefotaxime, Ceftiaxone  No 1 
B 5 2006 GT09401597 Cefotaxime, Ceftriaxone  No 1 
B 3 2006 GT09378327 Vancomycin Cloxacillin, Penicillin, 
Ampicillin, Erythomycin, 
Clindamycin, Cotrimoxazole
Yes 1 
J 6 2006 GT00407562 Penicillin, Ampicillin, Erythromycin, 
Cloxacillin 
 No 2 
B 11 2006 GT25378030 Penicillin, Ampicillin, Erythromycin, 
Cloxacillin, Clindamycin 
Penicillin, Ampicillin Yes 2 
J 11 2006 GT00441951 Erythromycin, Cotrimoxazole, 
Cloxacillin, Chloramphenicol, 
Clindamycin 
Penicillin, Ampicillin Yes 1 
B 2 2006 GT09345756 Ampicillin, Cloxacillin  No 2 
B 2 2006 GP08786445 Penicillin  No 1 
B 3 2006 GT09378327 Penicillin, Vancomycin, Fucidic acid  No 2 
B 3 2006 GT00032207 Penicillin  No 1 
B 7 2006 GP08805735 Cefuroxime, Co-amoxiclav, 
Gentamicin, Cotrimoxazole 
Ampicillin, Amoxycillin Yes 1 
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B 5 2006 GT09399932 Penicillin, Ampicillin, Erythromycin, 
Cloxacillin, Clindamycin 
Penicillin, Ampicillin Yes 2 
B 6 2006 GT08750760 Penicillin  No 1 
B 5 2006 GT25566364 Cloxacillin, Clindamycin, 
Cotrimoxazole, Ampicillin 
Penicillin, Ampicillin Yes 3 
B 5 2006 GT09405292 Penicillin, Ampicillin  No 2 
B 5 2006 GT09407142 Cloxacillin  No 1 
B 6 2006 GT09408339 Penicillin, Ampicillin, Cefotaxime, 
Ceftriaxone 
 No 1 
B 6 2006 GT09410519 Penicillin, Ampicillin, Erythromycin  No 1 
B 6 2006 GT09410530 Etrapenem, Ciprofloxacin, 
Gentamicin, Amikacin 
Co-amoxiclav, Cefazolin, 
Cefalexin, Ampicillin, 
Amoxycillin, Cefuroxime, 
Ceftriaxone, Pip-Taz 
Yes 1 
B 6 2006 GT08706651 Ampicillin, Vancomycin, Cefuroxime Cloxacillin No 3 
J 6 2006 GT00403025 Penicillin, Ampicillin, Erythromycin, 
Clindamycin 
 No 1 
B 4 2006 GT08907215 Co-amoxiclav, Tetracycline, 
Cefotaxime, Cetriaxone 
Ampicillin, Cotrimoxazole Yes 1 
 
